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Poly-N-acetylglucosamine (PNAG) is an important Staphylococcus aureus 
virulence factor.  It is a major component of the extracellular polymeric matrix in biofilms, 
and contributes to resistance to the innate immune response. The proteins encoded in the 
icaADBC (intercellular adhesin) operon are responsible for PNAG production.  Here, we 
present evidence of a new mechanism of phase variation for switching off PNAG 
production that involves slipped strand mutagenesis, along with further insight into the 
regulation and expression of the icaADBC operon. S. aureus strain MN8m (mucoid) is a 
	   xiv	  
spontaneous mutant of strain MN8 (non-mucoid). It is characterized by constitutive 
overproduction of PNAG, resulting from a 5 bp deletion in the icaADBC promoter region. 
First, we explored the effect of this mutation on the binding of the positive regulator SarA 
and its regulation of icaADBC in MN8m; and demonstrated that while binding is not 
inhibited by the MN8m promoter mutation, it appears that SarA exhibits a negative 
influence on transcriptional activation in this strain background. Second, we found that 
non-mucoid mutants were frequently detected in MN8m cultures. The PNAG mutants still 
exhibited elevated icaADBC transcript levels and the 5 bp deletion was still present, but 
they were PNAG-negative. The most frequent mutation responsible for the phenotype 
was a slipped strand mispairing in the icaC gene. We found that, in vitro, PNAG-negative 
mutants had a growth advantage and increased fitness relative to the mucoid, PNAG-
overproducing strain. Therefore, the slipped strand mutants in the PNAG-off state had a 
competitive growth advantage and eventually predominated the culture. Reversion back 
to mucoid occurred but revertants were isolated infrequently, due to their compromised 
fitness. The region of slipped strand mispairing was found to vary in several clinical S. 
aureus isolates, indicating in vivo relevance of this new mechanism. Third, a non-mucoid 
variant was isolated with the same phenotype and growth properties that instead had a 
nonsense mutation in icaB, which has demonstrated that there is a polar translational 
relationship between icaB and icaC. Together, these studies have given us insight into 
the regulation and expression of icaADBC expression and have revealed a growth 
disadvantage associated with PNAG overproduction.  
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CHAPTER 1 
Introduction 
 
 
 
Clinical Significance of Staphylococcus aureus 
 
Staphylococcal bacteria are Gram-positive cocci that are part of the family 
Staphylococcaceae in the order Bacillales. The staphylococci are non-motile, non-spore 
forming facultative anaerobes, capable of growth by either aerobic respiration or 
fermentation. Staphylococci are oxidase negative and predominantly catalase positive, 
allowing them to be distinguished from streptococci. Staphylococcus aureus and 
Staphylococcus epidermidis are the most studied and well-characterized species of the 
genus. Staphylococcus aureus is of particular clinical importance because it is a major 
opportunistic pathogen responsible for a large range of infections that contribute 
significantly to morbidity, mortality and healthcare costs. It can be found commensally 
on mucosal surfaces such as the anterior nares, and transiently on the skin. S. aureus 
is a leading cause of nosocomial infections, particularly on indwelling medical devices. 
Infections occur when the bacteria cross the epithelial boundary, where they are 
capable of infecting a wide variety of body tissues. Mild soft tissue skin infections 
caused by S. aureus such as impetigo and foliculitis are generally self-limiting. 
However, more severe life-threatening infections including osteomyelitis, bacteremia, 
toxic shock syndrome, necrotizing pneumonia and infective endocarditis are commonly 
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caused by S. aureus. In fact, in the United States and Canada, S. aureus is the most 
common cause of skin/soft tissue infection, bacteremia, and nosocomial lower 
respiratory tract infections (Diekema et al., 2001). Additionally, deaths from methicillin 
resistant S. aureus (MRSA) alone exceed 18,000 yearly in the United States, making it 
the leading cause of death by a single infectious agent (DeLeo & Chambers, 2009). 
Treatment of S. aureus infections is complicated by its tendency to acquire resistance to 
the antibiotics commonly used to combat infection, quickly becoming multi-drug 
resistant. Oxacillin/methicillin resistance (MRSA) is widespread in both hospital and 
community settings, with numerous vancomycin resistant (VRSA) strains already 
emerging as well (DeLeo & Chambers, 2009, Howden et al., 2010). In 2010, S. aureus 
was reported to have acquired resistance to some of the newest antibiotics approved as 
last resorts for treatment, daptomycin and linezolid (Nannini et al., 2010). S. aureus 
expresses an arsenal of virulence factors that allow it to establish infection and survive 
challenge. It can produce proteins and polysaccharides that inhibit complement and 
opsonization, as well as toxins, proteases, and superantigens (Foster, 2005). S. aureus 
also encodes various adhesion proteins/polysaccharides, and its ability to form a 
hardy/adherent biofilm can contribute to virulence. This proficient biofilm formation is 
associated with medical implant infections, although biofilm-associated infections can 
also be associated with host tissue. Examples of staphylococcal biofilm-associated 
infections include but are not limited to chronic rhinosinusitis, acute septic arthritis, 
endophthalmitis, chronic bacterial prostatitis, and native-valve endocarditis. 
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Biofilms 
 
A biofilm is an aggregation of sessile bacteria that are encased in a 
predominantly self-produced extracellular polymeric substance/matrix (EPS) that holds 
them together and onto a surface. The extracellular polymeric matrix can be composed 
of bacterial proteinaceous adhesins, teichoic acids, extracellular DNA, and/or 
polysaccharides (Cucarella et al., 2001, Izano et al., 2008, Gross et al., 2001). The ratio 
of these different EPS components is highly variable, changing in response to various 
stimuli; and can vary between different sites of infection or within a single biofilm at 
different points in time. The exact process of biofilm formation is difficult to define since 
different environmental conditions and bacterial genetic backgrounds can influence the 
function of numerous regulators, adhesins, and enzymes, causing a large degree of 
variation in physical characteristics. Cell-cell communication (quorum sensing) is 
optimized within a biofilm, since cells are held together closely, permitting coordinated 
gene expression and maturation of the biofilm over time (Davies et al., 1998).  
 Initial adherence of planktonic bacteria to a surface begins the process of biofilm 
growth, when cells begin deposition of the EPS molecules encouraging intercellular 
aggregation. As a biofilm matures it develops a distinct physical architecture to maintain 
hydration and the flow of nutrients to the resident bacteria that is characterized by 
tower-like structures interspersed with fluid-filled channels (Costerton et al., 1995). As a 
biofilm becomes fully mature, individual planktonic cells or small clumps of intact biofilm 
may be dispersed into the surrounding environment to seed new sites of infection.  
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 The biofilm mode of growth confers several different survival advantages on the 
resident bacteria, including a high degree of resistance to environmental forces like UV 
light, sheer force, and desiccation. The biofilm is also capable of shielding cells from the 
host immune response (Vuong et al., 2004b) and challenge with numerous different 
types of antibiotics. In fact, biofilm bacteria are able to withstand antibiotic 
concentrations up to 1000-fold higher than their genetically identical planktonic 
counterparts (Hoyle & Costerton, 1991). Several different aspects of biofilm formation 
have been suggested to contribute to these significant survival advantages. Biofilms are 
organized into different regions of altered metabolic activity based upon the availability 
of nutrients and external stimuli. Bacteria tend to become less aerobic and growth is 
slowed as proximity from the edges of the biofilm diminish, resulting in a sub-population 
of cells that are intrinsically resistant to antibiotics that depend on active cellular growth 
for their mode of killing (Brown et al., 1988). This resistance effect is heightened by the 
extrapolymeric matrix surrounding the cells within a biofilm. The EPS molecules at the 
biofilms exterior perimeter may slow penetration of a certain antimicrobials through 
electrostatic properties or size/physical properties, depleting the local lethal 
concentration and/or allowing more time for cells further within the biofilm to react 
(Vuong et al., 2004b, Walters et al., 2003). Additionally, recent evidence points to 
increased concentration of a sub-population of persister cells within biofilms (Keren et 
al., 2004). Persister cells are dormant cells that are highly tolerant to a variety of 
antibiotics, and they are capable of reestablishing a biofilm infection after even 
extremely high concentrations of antimicrobials that have been applied are removed, 
complicating complete eradication of a biofilm infection and leading to relapse. Biofilm-
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mediated resistance is a phenotypic trait, and if an established biofilm can be 
successfully dispersed the bacteria regain planktonic levels of sensitivity to antibiotics 
and to host immune defenses. 
 
Staphylococcal Biofilms 
A wide variety of extracellular adhesive matrix components have been identified 
as mediators of staphylococcal biofilms. Extracellular DNA, either derived from lysed 
bacteria or potentially from other sources (such as DNA released by neutrophils during 
host immune response), has been shown to be a major component of staphylococcal 
biofilm extracellular matrix, particularly in S. aureus biofilms (Izano et al., 2008). 
Staphylococcus aureus also expresses a large variety of surface-associated 
proteinaceous adhesins that can contribute to the composition of the EPS. Additionally, 
other surface expressed proteins can play a role, including different MSCRAMMs 
(microbial surface components recognizing adhesive matrix molecules), such as 
fibronectin-binding proteins (FnbpA, FnbpB), collagen-binding protein, clumping factors 
(ClfB), and SasG. Polysaccharide adhesins can also mediate biofilm formation, and one 
of the most prominent and well-characterized adhesive molecules in S. aureus 
infections is the polysaccharide poly-N-acetylglucosamine. 
 
icaADBC and Poly-N-acetylglucosamine 
A major component of the S. aureus biofilm extracellular matrix, and an important 
virulence determinant in S. aureus infections in general, is the polysaccharide poly-N- 
acetylglucosamine. Poly-N-acetylglucosamine (PNAG), also referred to as 
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polysaccharide intercellular adhesin (PIA) in S. epidermidis, is a high molecular weight 
polymer of β-1-6-linked N-acetyl-glucosamine (Mack et al., 1996, Maira-Litran et al., 
2002). In addition to its role in intercellular adhesion and biofilm formation, PNAG also 
plays a role in immune evasion (Cerca et al., 2007, McKenney et al., 1998). PNAG is 
synthesized by the proteins encoded in the icaADBC intercellular adhesin locus (Fig. 1 
& 2). IcaA is a transmembrane glucosyltransferase that, together with IcaD, produces 
short PNAG oligomers (Gerke et al., 1998). IcaC is an integral membrane protein that is 
necessary for linking the short oligomers into longer polymer chains, and is thought to 
be involved in translocation of these chains to the cell surface (Gerke et al., 1998). 
Once there, IcaB is responsible for partial deacetylation of the PNAG molecule, which is 
required for retention at the cell surface (Vuong et al., 2004a). There are multiple known 
regulators of the ica locus. The icaR gene is located upstream of the icaADBC operon. 
It is a direct transcriptional repressor that is divergently transcribed from the rest of the 
operon. CodY has also been demonstrated to act as a negative transcriptional regulator 
(Majerczyk et al., 2008). The S. aureus global regulator SarA is an important positive 
regulator of ica that has been shown to bind in and around its promoter region (Tormo 
et al., 2005).  
 
Staphylococcus aureus strain MN8m 
S. aureus strain MN8m has proven to be a useful tool for investigating the role of 
PNAG is biofilm formation, due to its defining characteristic as a PNAG over-producing 
strain. MN8m was originally isolated as a spontaneous mutant by virtue of its mucoid 
phenotype from a chemostat culture of strain MN8, a toxic shock syndrome clinical 
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isolate (Cramton et al., 1999). The mutation that conferred this PNAG-overexpression, 
or the mucoid phenotype, was identified as a 5-bp deletion in the icaADBC promoter  
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Figure 1: Organization of the icaADBC operon. The Ica proteins are encoded by the 
icaADBC locus, which includes the divergently transcribed icaR gene. 
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   10	  
Figure 2: Roles of IcaADBC in PNAG synthesis. The exopolysaccharide poly-N-
acetylglucosamine (PNAG) is synthesized by the Ica proteins. (1) IcaA, a 
transmembrane glucosyltransferase, assembles short PNAG oligomers in conjunction 
with the IcaD membrane protein. (2) The PNAG precursors are then assembled into 
growing polymer chains by the transmembrane protein IcaC, which is thought to then 
translocate them to the cell surface. (3) IcaB is located on the cell surface and is 
responsible for partial deacetylation of the PNAG molecule, introducing random 
positively charged regions to the polymer, allowing it to be surface retained. 
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Figure 3. Schematic representation of the promoter region of the MN8 ica operon. 
Promoter elements, effector binding sites, and transcriptional start sites (TSS) are 
labeled. The five nucleotides underlined in purple at the TSS of icaR represent the 5 bp 
deleted in the mutation from MN8 to MN8m, previously identified as responsible for the 
conversion. 
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region (Jefferson et al., 2003) (Fig. 3). The mutation leads to constitutive icaADBC 
transcription, but the molecular basis for this overexpression has not been defined. 
Preliminary evidence shows that the effect is not mediated by interference of the 
deletion with the transcriptional start site of the divergently transcribed negative 
regulator IcaR, since the complete absence of icaR does not stimulate icaADBC 
transcription to the extent that is observed in strain MN8m. 
 
Research Objectives 
 
 Staphylococcus aureus infections are of particularly important clinical 
significance due their widespread nature, enormous expense associated with treatment, 
and high morbidity and mortality.  The ability of S. aureus to rapidly develop antibiotic 
resistance has led to the pursuit of alternative therapeutic approaches. Recent 
recognition of the major role that biofilm formation plays in many S. aureus infections 
has made it a major target of interest for new treatment development. Many of the 
proposed anti-biofilm therapies focus on inhibition, reversal, or dispersal of the biofilm 
phenotype by targeting the extracellular polymeric matrix. In order for this to be a viable 
new approach to treatment, our understanding of how the adhesive molecules that 
make up the EPS matrix are regulated, must be expanded and improved. Although the 
role of PNAG in S. aureus biofilms as an adhesin has been well established, our 
knowledge about its regulation remains incomplete. The goal of this project is to utilize a 
strain that over-produces PNAG to better elucidate details of the expression and 
regulation of the icaADBC operon responsible for PNAG synthesis. First, to better 
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understand promoter-regulator interactions and promoter characteristics that influence 
transcriptional activation. Secondly, to explore new evidence that PNAG expression can 
be modulated by phase variation within a biofilm population to reduce its contribution. 
These objectives have resulted in characterization of a novel form of phase variation 
PNAG that suggests a potential for roles of the icaADBC genes beyond PNAG 
synthesis, and the realization of a previously unknown polar relationship between genes 
of the operon. This study also provides new insight into the role of SarA in icaADBC 
activation, and further characterization of the molecular mechanism responsible for 
over-production of PNAG in S. aureus strain MN8m. 
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CHAPTER 2 
Materials and Methods 
 
 
 
 
Staphylococcal strains and culture conditions. Bacterial strains used in these studies 
are listed in Table 1. Staphylococcus aureus strains were grown aerobically at 37°C on 
tryptic soy agar (TSA) plates containing the appropriate antibiotic. Liquid cultures were 
in tryptic soy broth containing 1% glucose (TSBG), incubated aerobically at 37°C, 200 
rpm. Congo red agar, used to asses mucoid phenotype by colony morphology, was 
composed of brain heart infusion (BHI) agar + 3.6% sucrose + 0.5% glucose + 0.08% 
Congo red. Escherichia coli strains were grown aerobically at 37°C on Luria-Bertani 
broth (LB) agar plates containing the appropriate antibiotic. E. coli liquid cultures were in 
LB, incubated aerobically at 37°C, 200 rpm. Appropriate antibiotics were incorporated at 
the following concentrations: 100 µg/ml ampicillin (Amp) for E. coli,  35 µg/ml 
chloramphenicol (Cm) for E. coli, 10 µg/ml Cm for S. aureus, 5 µg/ml tetracycline (Tet) 
for S. aureus, and 10 µg/ml erythromycin (Erm) for S. aureus. 
 
Agarose gels. 1.0% agarose gels were prepared by dissolving agarose in 1X Tris-
acetate-EDTA (TAE) buffer (Fisher Scientific, Pittsburg, PA), with 0.15 µg/mL ethidium 
bromide added before pouring. 10X BlueJuice loading buffer (Invitrogen, Grand Island, 
NY) was added to DNA samples to achieve a 1X final concentration. Gels were run 
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Table 1. Bacterial strains 
S. aureus Strains Description Source 
 
MN8 
 
Nonmenstrual toxic shock syndrome 
clinical isolate 
 
 
 
(Schlievert & 
Blomster, 1983) 
MN8∆ica::tet icaRADBC mutant of S. aureus MN8 
(Tetr) 
 
 
(Jefferson et al., 
2003) 
MN8∆sarA::erm sarA mutant of S. aureus MN8 (Ermr) 
 
 
 
Jefferson lab strain 
MN8m Spontaneous mucoid mutant isolated 
from a chemostat culture of S. aureus 
MN8 
 
(Cramton et al., 
1999) 
JB12 Spontaneous non-mucoid mutant 
isolated from a chemostat culture of S. 
aureus MN8m 
 
This study 
 
JB12 + pCL15 Complementation of JB12 with pCL15 
(Cmr, empty vector) 
 
 
This study 
 
JB12 +pCL15-icaC Complementation of JB12 with icaC 
from MN8m in trans using pCL15 (Cmr) 
Primers: icaCSphIFwd, icaCKpnIRev 
 
 
This study 
 
JB17 Spontaneous non-mucoid mutant 
isolated from a chemostat culture of S. 
aureus MN8m 
 
This study 
JB17 + pCL15 Complementation of JB17 with pCL15 
(Cmr, empty vector) 
 
 
This study 
 
JB17 + pCL15-icaB Complementation of JB17 with icaB 
from MN8m in trans using pCL15 (Cmr) 
Primers: icaBBamHIFwd,icaBEcoRIRev 
 
 
This study 
 
JB17 + pCL15-icaC (native) Complementation of JB17 with icaC 
from MN8m in trans using pCL15 (Cmr) 
Primers: icaCSphIFwd, icaCKpnIRev 
 
 
This study 
 
JB17 + pCL15-icaC (ideal) Complementation of JB17 with icaC 
from MN8m with a modified ribosomal 
binding site, in trans using pCL15 (Cmr) 
Primers: icaCRBSFwd, icaKpnIRev  
This study 
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JB17 + pCL15-icaBC Complementation of JB17 with icaBC 
from MN8m in trans using pCL15 (Cmr) 
Primers: icaBSphIFwd, icaCKpnIRev 
 
 
This study 
 
ALC1342∆sarA::erm sarA mutant of S. aureus RN6390 
(Ermr) 
 
 
(Cheung & Manna, 
2005) 
RN4220 Restriction defective derivative of S. 
aureus RN450 
 
 
(Kreiswirth et al., 
1983) 
RN4220∆ica::tet icaRADBC mutant of S. aureus RN4220 
(Tetr) 
 
 
Jefferson lab strain 
RN4220∆ica::tet + pBT9-M1 Complementation of RN4220 icaADBC 
mutant with icaRADBC from MN8m in 
trans using pBT9 (Tetr, Cmr) 
 
This study 
 
RN4220∆ica::tet ∆sarA::erm    
+ pBT9-M1 
Complementation of RN4220 sarA and 
icaRADBC mutant with icaRADBC from 
MN8m in trans using pBT9 (Tetr, Cmr) 
 
This study 
 
 
E. coli Strains Description Source 
 
CH3 Blue 
 
Chemically competent cells derived from 
E. coli K12, cloning strain (Ampr when 
transformed with plasmid) 
 
 
Bioline (Tauton, MA) 
BL21-CodonPlus(DE3)-RIL Chemically competent cells derived from 
E. coli BL21, heterologous protein 
expression strain (Ampr when 
transformed with plasmid, Cmr) 
 
Stratagene (La Jolla, 
CA) 
BL21 + pET32xT-sarA BL21-CodonPlus(DE3)-RIL cells 
containing sarA from MN8 in trans using 
pET32xT (Ampr, Cmr) 
This study 
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at 125 volts in 1X TAE buffer and visualized under UV light. DNA size was determined 
by comparison against the Hyperladder series of DNA molecular weight markers 
(Bioline, Taunton, MA). 
 
Biofilm growth assay. Microtiter plate assays for biofilm formation were performed 
essentially as described previously by Christensen et al. (1985) with minor 
modifications. Cultures were grown overnight in 4 ml of TSBG or TSBG + 10 µg 
chloramphenicol/ml, diluted 1:200 in the same media or media with 1mM IPTG added 
for plasmid induction, and aliquoted into 96-well polystyrene flat-bottom microtiter plates 
(Greiner Bio-One, Monroe, N. Carolina). After 24 hours at 37°C, the wells were emptied 
and washed once with phosphate-buffered saline (PBS). The plates were dried at room 
temperature, stained with 200 µl safranin for 1 minute, washed gently with water, and 
allowed to dry. The biofilms were assessed qualitatively by visual inspection and images 
were taken using a digital scanner. The safranin was then resuspended in 200 µl 33% 
acetic acid and the wells were analyzed by spectrophotometry at OD562 nm using a 96-
well plate spectrophotometer. 
 
Planktonic growth assay. To generate a bacterial growth curve, cultures were grown 
overnight in TSBG, and gently sonicated for 30 seconds. Each culture was diluted to 
OD600nm of 0.1 and used to inoculate fresh TSBG 1:100, with separate tubes for each 
time point. The cultures were incubated at 37°C, 200 rpm. At each time point the 
cultures were gently sonicated, the OD600nm measured, and then serially diluted and 
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plated in triplicate on TSA plates to determine the number of colony forming units 
(CFU). 
 
gDNA extraction. To isolate genomic DNA, bacteria were grown overnight in liquid 
cultures, diluted to OD600nm = 1.0 in 1 ml total volume, and collected by centrifugation. 
The bacterial pellets were resuspended in 180 µl of lysis buffer, composed of 2.4 µl 
Triton X-100, 10 µl 5 mg/ml lysostaphin, and 20 mg lysozyme in 190 µl 1X TE buffer (10 
mM Tris-HCl pH 7.5, 1 mM EDTA); and incubated for 30 minutes at 37°C. The Qiagen 
DNeasy Blood and Tissue kit (Qiagen, Valencia, CA) was used from this point to extract 
the gDNA. Samples were incubated with 25 µl proteinase K and 200 µl Buffer AL at 
56°C for 30 min, and 200 µl 100% ethanol added. The mixture was transferred to 
DNeasy Mini spin column, centrifuged at max speed for 1 minute, and the column was 
then washed with 500 µl Buffer AW1. After repeating centrifugation, 500 µl Buffer AW2 
was added and the column dried by centrifugation at max speed for 3 minutes. gDNA 
was eluted by application of 200 µl sterile water directly to the column membrane, 
followed by centrifugation for 1 minute.  
 
Polymerase chain reaction (PCR) and product purification. Similar general conditions 
were used for all PCR amplification of DNA with slight modifications dependent on the 
DNA template to be used, product size, or the melting temperature (TM) of the primer 
set. Reaction mixtures were typically 50 µl total volume composed of 10 µl 5X Phire 
buffer (Thermo Scientific, Waltham, MA), 1.5 µl 10mM dNTPS (2.5 mM of each), 10 
pmol of both the forward and reverse primers, DNA template and 1 µl Phire II 
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polymerase in sterile water. For reactions using gDNA as template 3 µl was added; 
whereas only 1 µl was used for reactions based on plasmid DNA or DNA products 
purified from previous PCR’s. Template material for colony PCR was obtained by 
resuspended a single colony in 10 µl sterile water, and using 3 µl of the mixture for the 
reaction. Reaction conditions were programmed into a thermal cycler machine as: hot 
start at 105°C, initial denaturation at 95°C for 2 minutes, followed by 35 cycles of 94°C 
for 30 seconds, TM + 3°C of the lower primer TM for 30 seconds, and 72°C for 15 
seconds per kb of expected product size, and a round of final extension at 72°C for 10 
minutes. PCR products were purified after electrophoresis in agarose gel using the 
QIAquick Gel Extraction kit (Qiagen, Valencia, CA) as described by the manufacturer.  
 
Plasmid DNA purification and manipulation. Plasmid purifications were performed using 
the QIAprep Spin Miniprep kit (Qiagen, Valencia, CA) according to the manufacturer’s 
instructions, from overnight cultures of E. coli single colony transformants in 3 ml LB 
with ampicillin. All restriction enzymes, specific buffers, and BSA used for restriction 
enzyme digests of plasmid DNA or PCR products were purchased from New England 
Biolabs (Ipswich, MA), and used according to the manufacturer’s recommendations. 
After plasmid restriction digestion, the 5’ phosphoryl groups were removed using 
Antarctic Phosphatase and its supplied buffer (New England Biolabs, Ipswich, MA) 
according to manufacturer’s instruction, to prevent re-ligation. Ligation of DNA fragment 
inserts into digested plasmids was accomplished using Ready-To-Go T4 DNA Ligase 
and Ligase Buffer (Amersham Biosciences, Piscataway, NJ) at roughly a 3:1 ratio of 
insert to plasmid, at 16°C for a minimum of 1 hour. 
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Table 2. Primer List 
Primer Name Sequence 
 
icaseq1 
 
5’-CAAGTGTTGTACCGTCATACC-3’ 
 
icaseq2 
 
5’-CGTCGATTTACAAGAAAACAGAGG-3’ 
 
icaseq3 
 
5’-AGGTCTTTGGAAGCAACGCG-3’ 
 
icaseq4 
 
5’-ATCGCTATATCTTGTGTCTTTTGG-3’ 
 
icaseq5 
 
5’-AAATGGCTAAAATCACATGATGC-3’ 
 
icaseq6 
 
5’-TACCGGTAATCAAAAAAGCTGGG-3’ 
 
icaseq7 
 
5’-GTCCTATTAGGTCAATGGTATGG-3’ 
 
icaseq8 
 
5’-GAGGATAATACAATGGTCTTTCTAGC-3’ 
 
icaseq9 
 
5’-CACTCCCATTGGCATTTACGAAG-3’ 
 
icaseq10 
 
5’-CCAATAGTCTCCATTTGCTAACGC-3’ 
 
icaseq11 
 
5’-ACGCGTGTAGTTAAGTATCTATAGG-3’ 
 
icaseq12 
 
5’-GATAAGTTATGCAAATCGTGGGTATG-3’ 
 
icaseq13 
 
5’-ACCATCCAGTGTGCTTACAGG-3’ 
 
icaseq14 
 
5’-GCGACTATCAATAAAGAGTGCGACTG-3’ 
 
icaseq16 
 
5’-CCAGCAAGTGTCTGACTTCG-3’ 
 
icaseq16 
 
5’-CATCCACATTTATGTCAGGCTTC-3’ 
 
sarAFwd 
 
5’-CGCGGATCCGCAATTACAAAAATCAATGATT-3’ 
 
sarARev 
 
5’-GGGCTCGAGTTATAGTTCAATTTCGTTGTT-3’ 
 
icaBBamHIFwd 
 
5’-CCGCGGATCCCAAAAATGGCAGAGAGGAAGA-3’ 
 
icaBEcoRIRev 
 
5’-CCGCGAATTCAGCACGTAAATATACGAGTTCAAGT-3’ 
 
icaBSphIFwd 
 
5’CCGCGCATGCCAAAAATGGCAGAGAGGAAGA-3’ 
 
icaCSphIFwd 
 
5’-CCGCGCATGCCAAAAATGGCAGAGAGGAAGA-3’ 
 
icaCKpn1Rev 
 
5’-CCGCGGTACCCCGCGTGTTTTTAACATAGC-3’ 
 
icaCRBSFwd  (SphI) 
 
5’-CCGCGCATGCGAGCATTTAATTAAGAGATGAGGAGGATTC-3’ 
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16SRTFwd 5’- TATGCATCGTTGCCTTGGTA-3’ 
 
16SRTRev 
 
5’-GAACCGCATGGTTCAAAAGT-3’ 
 
icaCRTFwd 
 
5’-CGAACAACACAGCGTTTCAC-3’ 
 
icaCRTRev 
 
5’-CGTTCCAATAGTCTCCATTTGC-3’ 
 
icaRRTFwd 
 
5’-TTTGTAATTGCAACTTAATTTTCCTG-3’ 
 
icaRRTRev 
 
5’-AAACAACATTTAACACTTTGTTCGT-3’ 
 
sarARTFwd 
 
5’-TTGCTTTGAGTTGTTATCAATGG-3’ 
 
sarARTRev 
 
5’-TTTCTCTTTGTTTTCGCTGATG-3’ 
 
icaProBTFwd 
 
5’-TGTTACAGGAAAATTAAGTTGCAATTACA-3’ 
 
icaProBTRev-BioTEG 
 
5’-GGTTGTAAGCCATATGGTAATTGATAGT-3’ 
 
icaProBend1-Xba 
 
5’-TCTAGACTATGTTACAGGAAAATTAAGTTGC-3’ 
 
icaProBend2-Sal 
 
5’-GTCGACGATAGTATTTTAATTTGCAATAGATTGTTG-3’ 
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Transformation of chemically competent E. coli. One vial of chemically competent E. coli 
cells was thawed on ice; 4 µl of plasmid ligation reaction was gently added and 
incubated on ice for 30 minutes. The tube was transferred to a 42°C water bath for 30 
seconds, and placed back on ice until 200 µl SOC media  (85.5 mM NaCl, 2.5 mM KCl, 
10 mM MgCl2, 2% tryptone, 0.5% yeast extract, and 20mM glucose) could be added. 
The cells were allowed to recover at 37°C for 1 hour, and then plated on LB plates with 
appropriate antibiotic selection. 
 
Production of electrocompetent S. aureus RN4220. Overnight cultures of S. aureus 
RN4220 were grown shaking in TSB at 37°C, 200 rpm. The bacteria were subcultured 
by 1:100 dilution in fresh TSB, and grown to exponential phase (OD600nm = 0.5 to 0.8) at 
37°C, 200 rpm. Cell pellets were obtained by centrifugation for 15 minutes at 4°C, 4000 
rpm. All subsequent steps were carried out on ice, with pre-chilled reagents. The pellet 
was washed three times with 25 ml of ice cold sterile water, using 5 minute 
centrifugations to re-pellet cells in between washes. The pellet was then washed a final 
time in 30 ml cold 10% glycerol in water, before being resuspended in 15 ml 10% 
glycerol and incubated at room temperature for 15 minutes. The cells were then again 
collected by centrifugation, and the final pellet resuspended in 500 µl 10% glycerol. 
Aliquots (50 µl) were stored at -80°C until use. 
 
Transformation of electrocompetent S. aureus. One vial of electrocompetent S. aureus 
RN4220 cells was thawed on ice; 5 µl plasmid DNA was gently added and incubated on 
ice for 30 minutes. The mixture was then transferred to an electroporation cuvette with a 
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gap length of 0.1 cm and pulsed once using the Micropulser machine (Bio-Rad, 
Hercules, CA) pre-set S. aureus setting (1.8 kV, 2.5 msec, 25 µF). Immediately 
following electroporation, 500 µl of TSB containing the appropriate antibiotic (diluted 
1:500 from normal liquid culture concentration to a sub-inhibitory concentration) was 
added and the entire mixture transferred to a culture tube. The cells were allowed to 
recover at 37°C for 2 hours, and then plated on TSA plates with appropriate antibiotic 
and incubated overnight at 30°C. 
 
Phage transduction. The generalized transducing phage 80𝛼 was used to create allelic 
exchange mutants or to move plasmids between S. aureus strains. The donor strain 
was scraped from an overnight plate into 250 µl TSB until extremely turbid, which was 
then added to 0.4% soft TSA containing 5 µl of 2 M CaCl2. After addition of 75 µl of 
phage 80𝛼, the mixture was poured onto a TSA plate and incubated at 37°C until lysis 
occurred, indicated by clearing of the top agar. Following lysis, the soft top agar was 
collected, centrifuged, and the supernatant filter sterilized using a 0.45 µm syringe filter. 
The recipient strain was scraped from an overnight plate into 300 µl TSB until extremely 
turbid, and was divided into three 100 µl culture tubes containing 2.5 µl of 2 M calcium 
chloride each. Aliquots of the phage lysate, either 75 µl, 150 µl, or 250 µl were added to 
each of the tubes and the total volumes brought up to 2 ml with TSB. The mixtures were 
incubated shaking at 37°C for exactly 20 minutes, and 3 ml of 20 mM sodium citrate 
added. After centrifugation to collect the bacteria, the pellet was resuspended in 3 ml 
sodium citrate again and centrifuged. The remaining pellet was resuspended in 500 µl 
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20 mM sodium citrate, incubated at 37°C for 2 hours, and then plated on TSA 
containing the appropriate antibiotic to be incubated for 48 hours at 37°C. 
 
RNA isolation. Overnight liquid cultures were diluted 1:10 in 5 ml TSBG and incubated 
shaking for 4 hours at 37°C. The bacteria were collected by centrifugation and stored at 
-80°C, for a minimum of 1 hour or until use. RNA was extracted using the Qiagen 
RNeasy Mini kit (Qiagen, Valencia, CA) with some modifications. The pellets were 
resuspended in 500 µl Buffer RLT and transferred to 2 ml tubes containing 1mm glass 
beads (Research Products International Corp., Mount Prospect, IL). After adding 500 µl 
cold acid phenol, the cells were lysed twice using a FastPrep FP120 (Thermo, 
Pittsburgh, PA) at a speed setting of 6.0 for 40 seconds, cooling the tubes on ice for 5 
minutes between the runs. The aqueous phase was collected after centrifugation and 
mixed with 500 µl 100% ethanol. Samples were applied to an RNeasy spin column, and 
following manufacturer’s instructions, the column was washed once with 700 µl Buffer 
RW1 and twice with 500 µl Buffer RPE. The columns were dried by centrifugation at 
max speed for 3 minutes and the RNA eluted in 90 µl sterile, nuclease-free water. 
Contaminating DNA was digested with Turbo DNase (Ambion, Austin, TX) with the 
accompanying buffer for 1 hour at 37°C. The DNase was inactivated and removed using 
DNase Inactivation Reagent (Ambion) according to manufacturer’s directions. 
Absorbance was measured at 260 nm and 280 nm using a NanoDrop 10000 (Thermo 
Scientific, Waltham, MA), and the ratio of the two values was used to calculate the 
concentration of RNA. 
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cDNA synthesis. cDNA was synthesized from 1 µg of isolated mRNA by a two-step 
reverse transcription reaction using the Bioline Tetro cDNA synthesis kit (Bioline, 
Tauton, MA) according to manufacturer’s directions. The RNA was mixed with 10 pmol 
of up to six gene-specific reverse primers in 10 µl total volume, and incubated at 70°C 
for 10 minutes. 1 µl of 10mM dNTPs (2.5 mM of each), 1 µl RNase inhibitor, 4 µl 5X RT 
buffer, and 1 µl reverse transcriptase in 10 µl total volume was added to the RNA + 
primer mix. This was followed by incubation for 2 hours at 42°C, and 70°C for 15 
minutes. Control reactions (noRT) contained only RNA and water. 
 
Real-time RT-PCR. cDNA synthesized from isolated mRNA, or the noRT control, was 
diluted 1:10 in water for use with gene-specific primers, and 1:1000 for 16S reactions. 
The reaction mix was composed of 2 µl of the diluted cDNA, 10 pmol of both the forward 
and reverse primers, 8.5 µl sterile water, and 12.5 µl SYBER Green Sensimix (Bioline, 
Tauton, MA). Real-time RT-PCR was performed in a iQ5 Multicolor Realtime PCR 
Detection system (BioRad, Hercules, CA) following the programmed steps: 1 cycle of 3 
minutes at 95°C, 40 cycles of 20 seconds at 95°C, 20 seconds at 55.2°C, 20 seconds at 
72°C while collecting real time-PCR readings, and 41 cycles of 30 seconds at 55°C 
while collecting melting curve readings. Data was recorded in cycle threshold (Ct) for 
each sample in technical triplicate, and normalized to the 16S transcript level by 
calculating 2(16S Ct – Gene Ct). Ratios were determined between normalized sample values 
to produce fold differences.  
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Poly-N-acetylglucosamine (PNAG) slot blot. PNAG slot blots were performed essentially 
as described previously by Cramton et al. (2001) with minor modifications. Bacteria 
were grown overnight in TSBG or TSBG + 10 µg chloramphenicol/ml + 1mM IPTG. For 
cell surface extracts 109 cells were collected by centrifugation, washed once with PBS, 
and resuspended in 250 µl of 0.5M ethylenediaminetetraacetic acid (EDTA).  To 
analyze secreted PNAG, 250 µl of spent media was retained. All samples were 
incubated in boiling water for 5 minutes, cooled, and incubated at 65°C for 1 hour with 
20 µl proteinase K. Samples were boiled for an additional 5 minutes to inactivate the 
protease, diluted in 1X PBS, and immobilized on a nitrocellulose membrane that was 
pre-wetted in 10% methanol in 1X-PBS with a vacuum manifold.  The membrane was 
blocked overnight at 4°C in 5% bovine serum albumin diluted in 1X PBS, then probed 
with 1:5,000-diluted rabbit antiserum specific for PNAG (kindly provided Dr. Gerald B. 
Pier) (Maira-Litran et al., 2002) in 1X PBS + 1-2% blocking solution + 0.05% Tween-20 
(Fisher Scientific, Pittsburg, PA) for 2 hours at room temperature, while rocking. The 
membrane was washed three times for 5 minutes with 1X PBST (PBS + 0.05% Tween-
20), and then probed with 1:10,000- diluted goat anti-rabbit immunoglobulin-horseradish 
peroxidase conjugate (Invitrogen, Grand Island, NY) in 1X PBST for 1 hour at room 
temperature, while rocking. Bands were visualized with the ECL Plus western blotting 
detection system (GE Healthcare). The blot was incubated in the chemiluminescence 
developing reagent for 1 minute, covered in plastic wrap, exposed to X-ray film and 
developed in an X-O-Mat. 
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Isolation of JB12 mucoid revertants. Six-well polystyrene plates (CellTreat, Shirley, MA) 
were inoculated with individual colonies of JB12 in LB, grown at 37°C for 3 days, 
replacing the media every 24 hours. To collect mucoid revertants the wells were 
washed once with sterile 1X PBS, remaining adherent cells were scraped from the 
surface of the well and resuspended in PBS. After plating on CRA, colony morphology 
was visually assessed to identify mucoid CFUs. 
 
Fitness determination. Cultures were grown overnight in TSBG, and gently sonicated for 
30 seconds. Each culture was diluted to a concentration of 103 cells and mixed 1:1 with 
MN8m + JB12, with separate tubes for each time point. The cultures were incubated at 
37°C, 200 rpm. At each time point the cultures were gently sonicated, serially diluted 
and plated in triplicate on CRA plates for CFU counting. Calculation of the difference in 
fitness was determined using the function derived from Sander et al. (2002): 
Mt = ln  
 
where nmt and mt represent the non-mucoid and mucoid cells, respectively at a given 
time t. While nmt-1 and mt-1 denote the quantity of non-mucoid and mucoid cells at the 
preceding time point. The quotient of the ratios was standardized with the exponent 
1/generation, with the assumption that cell numbers determined at 24 hours represents 
approximately 17 generations. The relative bacterial fitness for a given time was 
calculated as fitt = 1 + Mt . The fitness value is equal to 1 if there is no difference in 
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fitness between the competing strains, less than 1 if the non-mucoid phenotype reduces 
fitness, or greater than 1 if the non-mucoid phenotype increases bacterial fitness. 
 
Cell survival in nutrient-limited conditions. Liquid cultures were initially grown shaking 
aerobically in TSBG for 24 hours at 37°C, 200 rpm. Bacteria were collected by 
centrifugation, and equal numbers of bacteria for each sample were resuspended in 
equal volumes of MOPS minimal media with no glucose, or other carbon source. The 
cultures were incubated at 37°C while shaking. At each time point the cultures were 
serially diluted and plated in triplicate on TSA plates for CFU enumeration. Each strain 
was analyzed in technical triplicate and biologic replicates.     
 
Polyacrylamide gel electrophoresis.  Protein gels were run using the NuPAGE SDS-
PAGE Gel system (Invitrogen, Grand Island, NY) according to manufacturer’s 
instructions with slight modifications. 100 µl of liquid cell culture was collected by 
centrifugation, resuspended in 50 µl sterile water, and mixed with 50 µl NuPAGE 4X LS 
Sample Buffer and 10 µl NuPAGE Sample Reducing Buffer (Invitrogen). Samples were 
incubated in boiling water for 5 minutes, gently sonicated, and loaded into the wells of 
NuPAGE 4-12% Bis-Tris 1.0 mm Gel (Invitrogen). The gel was electrophoresed for 
approximately 30 minutes at 200 V in 1X NuPAGE Running Buffer. Approximate protein 
size was determined by comparison against Precision Plus Protein Kaleidoscope 
standard (BioRad, Hercules, CA). Lanes were visualized by staining with Imperial 
Protein Stain (Thermo Scientific, Waltham, MA) for 1 hour, and destaining with water 
until bands were clearly visible. 
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Western blot to detect 6X-His-tagged proteins. A 0.45 µm PVDF membrane (Invitrogen, 
Grand Island, NY) was pre-wetted in 100% methanol, then soaked in 1X NuPAGE 
transfer buffer (Invitrogen) containing 10% methanol along with transfer paper and 
sponges. Following polyacrylamide gel electrophoresis, the gel was prepared for 
electrophoretic transfer by rinsing in deionized water and then placed against the PVDF 
membrane; surrounded by the transfer paper and sponges to maintain buffer saturation 
and tight contact between the membrane and gel, and immersed in the same 1X 
NuPage transfer buffer. The transfer was run at 40V for 1 hour at room temperature. 
The membrane was blocked overnight at 4°C in 5% skim milk diluted in 1X PBS, then 
probed with 1:1,000-diluted rabbit anti-6X HIS Tag primary antibody (Rockland 
Immunochemcials, Gilbertsville, PA) in 1X PBS + 1-2% blocking solution + 0.05% 
Tween-20 (Fisher Scientific, Pittsburg, PA) for 2 hours at room temperature, while 
rocking. The membrane was washed three times for 5 minutes with 1X PBST (PBS + 
0.05% Tween-20), and then probed with 1:10,000- diluted goat anti-rabbit 
immunoglobulin-horseradish peroxidase conjugate (Invitrogen, Grand Island, NY) in 1X 
PBST for 1 hour at room temperature, while rocking. Bands were visualized with the 
ECL Plus western blotting detection system (GE Healthcare). The blot was incubated in 
the chemiluminescence developing reagent for 1 minute, covered in plastic wrap, 
exposed to X-ray film and developed in an X-O-Mat. 
 
Production of recombinant SarA.  The primer set sarAFwd (BamHI site) and sarARev 
(XhoI site) were used to PCR amplify sarA from MN8 gDNA with directional restriction 
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sites on either end of the PCR product. After gel electrophoresis and purification by gel 
extraction, the PCR product was restriction digested with BamHI and XhoI (New 
England Biolabs, Ipswich, MA) according to manufacturer’s specification. The isopropyl 
β-D-1 thiogalactopyranoside (IPTG) inducible plasmid pET32xT was also digested with 
BamHI and XhoI, prior to ligation of the digested sarA insert into the vector. The plasmid 
construct was used to transform chemically competent E. coli CH3 blue cells (Bioline, 
Tauton, MA) with transformants being selected for on LB agar plates containing 
ampicillin. The plasmid construct was isolated using the previously outlined plasmid 
mini-prep procedure, and the sequence fidelity of the gene insert confirmed by 
nucleotide sequencing.  The pET32xT-sarA construct was then used to transform 
chemically competent E. coli BL21-CodonPlus(DE3)-RIL cells (Stratagene, La Jolla, 
CA), with transformants being selected for on LB agar plates containing ampicillin and 
chloramphenicol.  
To induce expression of recombinant SarA, a streak of many BL21+pET32xT-
sarA colonies was used to inoculate 50 ml of LB containing ampicillin and 
chloramphenicol, which was incubated shaking overnight at 37°C. The entire overnight 
culture was then transferred into 1 L of LB containing ampicillin and chloramphenicol, 
and incubated shaking at 37°C for 2 hours. A 1 ml aliquot was removed and saved prior 
to induction with 1 mM IPTG for 2 hours at 37°C. After protein induction, another 1 ml 
aliquot was removed and the entire remaining culture centrifuged to collect the bacterial 
cells. The pellet was washed once in sterile PBS, and frozen at -80°C for a minimum of 
1 hour. To confirm proper protein expression, the pre- and post-induction samples were 
run on a polyacrylamide gel as previously described, stained and visualized.   
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Purification of recombinant SarA. The induced BL21+pET32xT-sarA pellet was 
resuspended in lysis buffer on ice, and sonicated six times for 30 seconds at power 
level 5 while remaining on ice. Lysis buffer was composed of 20 mL B-PER Bacterial 
Protein Extraction Reagent (Thermo Scientific, Waltham, MA), 150 mM NaCl, 2 mM B-
ME, and one cOmplete EDTA-free protease inhibitor tablet (Roche Applied Science, 
Indianapolis, IN). The cell debris was removed by centrifugation, and the supernatant 
filter sterilized using a syringe capped with a pre-filter and a 0.45 µm pore filter. A 
purification column was prepared with 4 ml of HisPur Cobalt Resin (Thermo Scientific) 
washed once with sterile water and once with sterile 1X PBS. The filtered protein 
supernatant was applied to the column first, and was subsequently washed four times 
with 1X PBS + 10 mM imidazole and one wash with 1X PBS + 25 mM imidazole. 
Recombinant protein was eluted from the column with 1X PBS + 200 mM imidazole, 
and loaded into a 10K MWCO Slide-A-lyzer Dialysis Cassette (Thermo Scientific) to be 
dialyzed overnight in 3 L of 0.1X PBS stirring at 4°C. The protein was removed from the 
dialysis cassette and 200 units of thrombin (MP Biochemicals, Solon, OH) added, and 
allowed to incubate rocking overnight at room temperature. The mixture was then 
poured over a prepared 3 ml HisPur Cobalt Resin column, retaining the flow thru, which 
was concentrated to a final volume of 0.5-1 ml by centrifugation in a Amicon 3K Ultracel 
centrifugal filter unit (Millipore, Billerica, MA) and stored at 4°C on ice until use. The 
location of the expressed SarA protein was monitored throughout the purification 
process running all fractions collected on a polyacrylamide gel as previously described, 
stained and visualized.   
	   34	  
 
Electrophoretic mobility shift assay (EMSA). The biotinylated probes were generated 
using PCR with the icaProBTFwd and icaProBTRev-BioTEG (Integrated DNA 
Technologies, Coralville, IA) primers from either MN8 or MN8m gDNA. A 6.5% non-
denaturing polyacrylamide gel (30% acrylamide/ 0.8% bisacrylamide, 1X TBE, 100 µl of 
10% ammonium persulfate, and 10 µl TEMED for 15 ml total volume) was prepared. 
Approximately 0.2 µg of either biotinylated probe was added to 40 µl of binding buffer-2 
(20 mM HEPES pH 7.9, 1 mM DTT, 0.1 mM EDTA, 50 mM KCl, 5% glycerol, and 200 
µg/ml BSA) containing 0.5 µg non-specific competitor DNA poly d(I:C), and incubated 
on ice for 10 minutes. Recombinant SarA was added at varying concentrations, allowed 
to incubate on ice for 30 minutes, and run in the prepared gel at 150 V for 1 hour in 
0.25X TBE running buffer. A nylon membrane (Ambion, Austin, TX) was pre-wetted in 
0.25X TBE, and the gel contents electrophoretically transferred in the same buffer for 1 
hour at 40 V. DNA was UV cross-linked to the membrane using a Stratagene 
Stratalinker (La Jolla, CA) auto-crosslink function. Bands were visualized using the 
Thermo Scientific Chemilumiscent Nucleic Acid Detection kit (Waltham, MA) according 
to manufacturer’s directions, with one modification: Pierce High Sensitivity Streptavidin-
HRP  (Thermo Scientific, Waltham, MA) was used at 1:10,000 in place of the kit 
reagent. After application of the working solution for 3 minutes, the membrane was 
covered in plastic wrap, exposed to X-ray film and developed in an X-O-Mat.  
 
In silico prediction of curvature/bendability.  The nucleotide sequence surrounding the 
S. aureus MN8m 5 bp deletion in the ica promoter region, as well as the same intact 
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region from strain MN8 was submitted to the bend.it server; which calculated the 
bendability/curvature propensity plots, using the DNase I-based bendability parameters 
of Bruckner et al. (1995) and the consensus bendability scale (Gabrielian & Pongor, 
1996). 
 
Analysis of intrinsic DNA bending. PCR was used to amplify the selected ica promoter 
region with the icaProBend1-Xba and icaProBend2-Sal primers from either MN8 or 
MN8m gDNA with directional restriction sites on either end of the PCR product. After gel 
electrophoresis and purification by gel extraction, the PCR product was restriction 
digested with XbaI and SalI (New England Biolabs, Ipswich, MA) according to 
manufacturer’s specification. The plasmid pBEND2 was also digested with XbaI and 
SalI, prior to ligation of the digested ica promoter fragment inserts into the vector. The 
plasmid construct was used to transform chemically competent E. coli CH3 blue cells 
(Bioline, Tauton, MA) with transformants being selected for on LB agar plates containing 
ampicillin. The plasmid construct was isolated using the previously outlined plasmid 
mini-prep procedure in large quantity, and the sequence fidelity of the gene insert 
confirmed by nucleotide sequencing. Individual aliquots of approximately 100 µg of both 
the MN8 and MN8m-derived pBEND-icaPro constructs were restriction digested with 
BglII, NheI, SpeI, EcoRV, SspI, or BamHI (New England Biolabs). A 15 x 15 cm 10% 
polyacrylamide gel was prepared (1X Tris-Cl/SDS pH 8.8, 30% acrylamide/ 0.8% 
biasacrylamide, 350 µl of 10% ammonium persulfate, and 35 µl TEMED for 45 ml total 
volume). 1X loading buffer (5X stock composed of 25% glycerol and 2.5X TBE) was 
added to each of the plasmid digests prior to loading the gel, which was run at 30 V for 
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48 hours at 4°C. The gel was soaked in 0.5 µg/ml ethidium bromide for 30 minutes at 
room temperature and then visualized under UV light. DNA size was determined by 
comparison against the Hyperladder II DNA molecular weight marker (Bioline, Taunton, 
MA)
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CHAPTER 3 
Investigating the molecular mechanism responsible for icaADBC hyper-
transcription in Staphylococcus aureus strain MN8m 
 
 
 
 
Introduction 
Gene regulation can be modulated by means beyond the ability of the nucleotide 
sequence of DNA to encode proteins; the physical and structural characteristics of the 
DNA molecule itself may play an important role in influencing gene expression. There is 
ample evidence for the importance of DNA flexibility in the action of DNA-binding 
proteins altering the physical conformation of bound DNA, either to effect gene 
regulation through positive or negative control. Rigid DNA curvature reduces its 
bendability, and intrinsic curvature of the DNA results from certain nucleotide 
sequences. Tracts of A or T longer than 3 base pairs are considered to be major 
determinants of intrinsic curvature, and extended poly-A or poly-T tracts exhibit a 
particularly high degree of rigid curvature (Perez-Martin & de Lorenzo, 1997). Therefore, 
mutations can impact cellular processes not only because of how the change to the 
specific sequence affects transcription/translation/protein function directly, but also in 
how they alter the physical DNA architecture of the region they occupy. 
SarA is a major staphylococcal global regulator protein that has been implicated 
in the control of more than 120 different genes, and is an important positive regulator of  
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icaADBC transcription (Tormo et al., 2005). SarA is a dimeric protein composed of a 
central helical core and two winged helix motifs that each contain a helix-turn-helix 
motif, and both of which are capable of binding DNA (Liu et al., 2006). The winged 
domain recognizes the minor groove of DNA, while the helix-turn-helix interacts with the 
major groove. This binding of DNA compresses it, narrowing the minor groove and 
overwinding the helices, causing SarA-bound DNA to more closely resemble D-DNA 
that the more common B-DNA conformation (Schumacher et al., 2001). Recent work 
has begun to expand our knowledge of SarA beyond the traditional role of a classical 
transcription factor. It is unique in that it appears to demonstrate highly promiscuous 
binding affinity (DNA, RNA, etc), and is present in much higher amounts at all stages of 
growth than classic transcription factors, but is not always functionally active (Fujimoto 
et al., 2009). There is currently significant debate over how exactly SarA recognizes 
DNA, since binding is promiscuous and evidence of a consensus binding sequence thus 
far is weak and limited to AT-rich regions. An alternative theory was put forth by 
Fujimoto et al. (Fujimoto et al., 2000) which suggests that SarA is an architectural 
protein that instead recognizes specific physical/topological characteristics of DNA for 
binding. 
We have previously identified a spontaneous 5-bp deletion in the intergenic 
region between icaA and icaR that causes constitutive activation of the icaADBC 
operon, leading to an increase in PNAG production of up to 10,000-fold. The strain 
carrying this mutation, MN8m, has a distinct mucoid phenotype. However, the exact 
mechanism by which his small change induces such a profound increase in PNAG 
production remains unknown. We hypothesize that the deletion in the icaADBC  
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promoter region causes a significant change in the regional physical characteristics of 
the DNA, possibly allowing it to be more flexible in its interactions, leading to optimal 
transcriptional activation of icaADBC. We chose to include the interaction of SarA with 
our promoter region as a tool to better elucidate the mechanism responsible for 
increased PNAG production because it is a positive regulator of icaADBC that may 
influence transcriptional activity by altering the DNA topology/architecture. It is thought 
that it binds to and bends DNA in the 5ʼ region of the gene in such a way as to alter the 
spacing between the -10 and -35 regions (Fujimoto et al., 2009). We theorized that 
SarA binds to the icaADBC promoter region and maximizes the spacing, and that the 5-
bp deletion responsible for the mucoid phenotype maximizes this spacing even in the 
absence of SarA.  
 
Results 
Effect of MN8m promoter deletion on intrinsic DNA curvature/flexibility 
 We have hypothesized that a potential molecular mechanism underlying the 
constitutive icaADBC transcription of strain MN8m may be related to the 5-bp deletion in 
its promoter region causing a significant change in the physical characteristic in that 
region of DNA. Preliminary in silico analysis was performed using the bend.it server 
(Vlahovicek et al., 2003) to predict the effect of the deletion on the intrinsic DNA 
curvature and bendability of the 150 base pairs surrounding it (Fig. 4) since regions of 
bent DNA tend to span only a few dozen nucleotides. We found that alteration in the 
predicted characteristics was only observed in the 20 base pairs immediately  
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surrounding the deletion mutation site, a very small difference. We observed that the 
loss of those 5 base pairs reduced the predicted curvature of that region of DNA from 
approximately 3.0 °/helical turn to 0.5 °/helical turn, and slightly increased predicted 
bendability from 3.25 to 4 a.u. However, in general, values below 5.0 °/helical turn 
indicate a region of straight DNA with little to no curvature.  
 This observation was supported by our analysis directly comparing the intrinsic 
curvature of the altered DNA sequence in vitro using the plasmid vector pBEND2. The 
region of DNA from the ica promoter of both strains MN8 and MN8m inserted into the 
pBEND2 vector is shown in Figure 5.A. Use of the pBEND vector to determine 
curvature relies on the observation that the mobility of a DNA fragment in a 
polyacrylamide gel decreases as the center of any bent regions approaches the center 
of the fragment (Kim et al., 1989). Therefore restriction digest of pBEND2 containing the 
ica promoter region yields fragments of identical size with location of the inserted DNA 
fragment being varied (Fig. 5.B). Electrophoresis of the digested inserts, which differ 
only in the position of the predicted bending center, was analyzed to determine K values 
from the ratio of observed size to actual size of the two inserts with the greatest 
observed difference (Fig. 6, Table 3). Supporting the assumption that predicted 
curvature values of less than 5.0 °/helical turn indicating a region of straight DNA, K 
values of approximately 1.1 indicate no significant point of bending. Additionally, these 
results determine that the 5-bp deletion responsible for the constitutive transcription of 
icaADBC in MN8m does not have a detectable effect on this aspect of DNA topology in 
its vicinity. 
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Figure 4. In silico prediction of bendability/curvature effects of the MN8m 
promoter deletion. Bendability/curvature propensity plots generated by the bend.it 
server for the nucleotide sequence 150 bp around the deletion site; the deletion site is 
outlined. 
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Figure 5: Schematic representation of the DNA sequence region to be inserted 
into the pBEND2 vector. A.) The region of DNA containing the MN8m deletion site to 
be inserted into the pBEND2 vector is highlighted in pink. Putative SarA binding sites 
are indicated by the red lines, and other promoter function sites are labeled. B.) The 
multiple cloning site of pBEND2 with reciprocal restriction digest sites. The fragments 
generated by BglII, NheI, SpeI, EcoRV, SspI, and BamHI restriction digest are shown 
with the position of the insert indicated. 
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Figure 6: Analysis of intrinsic curvature of the promoter regions of S. aureus 
strains MN8 and MN8m. Restriction digests of pBEND2 containing either the MN8 or 
MN8m ica promoter segment electrophoresed on a polyacrylamide gel at 4°C, and 
visualized with ethidium bromide. Lane 1 contains BglII digested vector construct, lane 2 
NheI, lane 3 SpeI, lane 4 EcoRV, lane 5 SspI, and lane 6 BamHI. The digested 
fragments selected for curvature analysis are indicated in the boxed areas. 
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Table 3. Determination of MN8m ica promoter deletion on intrinsic DNA curvature 
Strain Origin of Insert Actual Size (bp) Observed Size (bp) K Value 
 
 
MN8 
 
 
 
203 
 
 
215 - 230 
 
 
1.059 - 1.133 
 
MN8m 
 
198 
 
215 - 225 
 
1.086 - 1.136 
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Expression and purification of recombinant SarA 
 The S. aureus global regulator SarA is an important positive regulator of ica that 
has been shown to bind in and around its promoter region (Tormo et al., 2005). We 
speculated that the 5-bp promoter deletion in the strain MN8m might influence binding 
of SarA leading to the increased icaADBC expression. To investigate how SarA 
interacts with the intact versus deletion-modified promoter region, we first needed to 
heterologously express and purify recombinant SarA. The sarA gene was cloned into 
the IPTG-inducible pET32xT vector (generously supplied by Dr. David Williams, VCU, 
Richmond, VA), which attaches a C-terminal Thio-HIS tag to the protein. The 
recombinant protein was expressed in E. coli BL21-CodonPlus(DE3)-RIL cells. 
Expression of the expected Thio-HIS-tagged SarA product was confirmed by SDS-
PAGE with the presence of a protein of approximately 34 kDa upon induction with 1 mM 
IPTG (Fig. 7.A), and by Western blot probed with 6X-HIS antisera showing a product of 
the same size after induction (Fig. 7.B). The expressed recombinant protein was 
isolated by column purification using cobalt resin (Fig. 8.A), and the Thio-HIS tag was 
removed by thrombin cleavage and separated from the 14.7 kDa SarA through 
repetition of cobalt column purification (Fig. 8.B). 
 
SarA binding to the ica promoter region 
To investigate our hypothesis that the MN8m deletion alters SarA binding 
to the ica promoter region, modulating PNAG expression, we utilized our purified 
recombinant SarA and the 100-bp region around the MN8m deletion (Fig. 9.A) for DNA 
binding gel shift assays. The DNA fragments from both MN8 and MN8m were 
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biotinylated and incubated with various amounts of the SarA protein, ranging from 0.01-
0.9 µg, in the presence of the non-specific oligo competitor poly d(I:C). The EMSAs for 
both promoter fragments showed that the 5-bp deletion in strain MN8m had no 
discernable effect on SarA binding to that region (Fig. 9.B). The retarded protein-DNA 
complexes were visible for both strains beginning at 0.1 µg of SarA. A complete shift 
was observed between 0.05 µg and 0.1 µg of SarA (the lower band for MN8 at 0.2 µg 
SarA was not observed in independent replicates, and variance in band intensity is 
experimental artifact). These results indicated that partial binding could be observed at 
SarA amounts between these two concentrations to further characterize the DNA-
binding affinity of SarA to this sequence fragment. Additionally, shifted bands of different 
sizes were observed at SarA amounts greater than 0.3 µg, supporting the existence of 
several SarA-binding sites within this region of the icaADBC promoter. 
 
Effect of SarA on the mucoid phenotype of MN8m 
 While we observed that the 5-bp deletion in the icaADBC promoter responsible 
for the mucoid phenotype of S. aureus strain MN8m does not affect SarA binding affinity 
for the region, we wanted to further elucidate the potential role of this positive regulator 
on the hyper-activation of the operon. It is thought that SarA binds to and bends 
promoter DNA in such a way as to optimize spacing, generally between the -10 and -35 
regions, and promote transcription (Fujimoto et al., 2009). We theorized that SarA binds 
to the icaADBC promoter region and maximizes the spacing (although it does not lie 
between the -10 and -35 regions) and that the 5-bp deletion responsible for the mucoid 
phenotype maximizes this spacing even in the absence of SarA. To investigate this  
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Figure 7: Heterologous expression of S. aureus 6X-HIS-tagged recombinant SarA 
in E. coli. (A) Imperial-stained SDS-PAGE of cell lysates of uninduced E. coli BL21-
CodonPlus(DE3)-RIL containing pET32xT-sarA, and the same strain induced for 2 
hours with 1 mM IPTG. Approximate molecular weights indicated. (B) Western blot of 
the same cell lysates probed with anti-6X-HIS Tag antiserum. Approximate molecular 
weights indicated. 
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Figure 8: Purification of S. aureus recombinant SarA. (A) Purification of 6X-HIS 
tagged recombinant SarA from culture lysate of IPTG-induced E. coli BL21-
CodonPlus(DE3)-RIL containing pET32xT-sarA using a cobalt resin column. An 
Imperial-stained SDS-PAGE gel, in which Lane 1 contains initial flow through after 
application of the culture lysate, Lane 2 represents the beginning of four column washes 
with 1X PBS + 10mM imidazole, Lane 3 contains a single wash with 1X PBS + 25mM 
imidazole, Lane 4 elution of the bound protein with 1X PBS + 200mM imidazole, and 
Lane 5 contains the remaining cobalt resin. Approximate molecular weights are 
indicated. (B) An Imperial-stained SDS-PAGE gel of the previous protein elution after 
treatment with thrombin to cleave the Thio-HIS tag from the recombinant SarA, and 
passage over a cobalt column to remove the tag. Approximate molecular weights are 
indicated.  
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Figure 9: Comparison of SarA binding to the MN8 and MN8m ica operon promoter 
regions. (A) Schematic representation of the nucleotide sequence (highlighted in pink) 
from both MN8 and MN8m that was biotinylated for use as specific binding probes. 
Putative SarA binding sites are indicated by red lines. (B) Electrophoretic mobility shift 
assays with biotinylated specific probes and non-specific competitor DNA, used to detect 
binding of SarA to the selected region of S. aureus strains MN8 and MN8m. Membranes 
were x-ray visualized after electrophoresis and electrophoretic transfer with streptavidin-
HRP. 
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hypothesis that SarA is non-essential for icaADBC expression in MN8m, we first 
constructed a group of isogenic S. aureus mutant strains: RN4220∆ica, 
RN4220∆ica+pBT9-M1 (in which the deletion has been complemented in trans by the 
entire icaRADBC locus under the control of the MN8m-type promoter on the vector 
pBT9), and RN4220∆ica∆sarA+pBT9-M1. When these three strains were plated on 
Congo red agar (CRA), we observed only non-mucoid colonies as expected for the 
PNAG-negative strain RN4220∆ica, which are slick, circular, and occasionally 
surrounded by a transparent red perimeter (Fig. 10). However, RN4220∆ica+pBT9-M1 
and its isogenic sarA mutant strain RN4220∆ica∆sarA+pBT9-M1 both formed mucoid 
colonies similar to those observed in strain MN8m, which appear dry with irregular 
edges. 
 The observation that there was no discernible difference in the mucoid colony 
morphology between the SarA-positive and SarA-negative strains, suggested that SarA 
may not be required for PNAG synthesis in strains containing the 5 bp deletion in the 
icaADBC promoter. To test this, we performed slot-blot analysis using PNAG-specific 
rabbit polyclonal antiserum. As depicted in Figure 11, no PNAG was detected in the ica-
negative strain, while it was detected on the surface of both RN4220∆ica+pBT9-M1 and 
RN4220∆ica∆sarA+pBT9-M1, supporting the previous observation of a mucoid 
phenotype. Not only was SarA not required for PNAG synthesis, but there actually 
appeared to be more PNAG present in the SarA-negative cultures, indicating a potential 
negative effect of SarA on expression of the mucoid icaADBC operon. 
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Role of SarA in MN8m icaADBC hyper-transcription 
The icaADBC genes are co-transcribed, so to determine the influence of SarA on 
levels of the full-length transcript produced by the mucoid promoter, we quantified levels 
of the 3’-most transcript, icaC, by realtime RT-PCR. As shown in Figure 12, icaADBC 
transcript levels were more than 30-fold greater in RN4220∆ica∆sarA+pBT9-M1 than in 
the isogenic SarA-positive strain RN4220∆ica+pBT9-M1. These results support the 
previous observation that SarA is not essential for icaADBC expression from the mucoid 
promoter. Furthermore, it appears that in the presence of the MN8m promoter deletion, 
SarA has a negative impact on transcriptional activation. 
 
Discussion 
 
 Virtually nothing is known about the molecular mechanism underlying the 
constitutive production of PNAG in S. aureus strain MN8m, aside from the fact that it is 
caused by a 5 bp deletion in the icaADBC promoter region. We have hypothesized that 
the increased transcriptional activation of icaADBC may be due to the mutation altering 
the topology or physical traits of the DNA structure in its vicinity. We have predicted and 
confirmed that the DNA in the icaADBC promoter region is predominantly linear, with no 
detectable intrinsic curvature, and that this does not change when the MN8m deletion is 
present. However, while we have shown that there is no intrinsic bend in the icaADBC 
promoter, this does not rule out that the 5 bp deletion in MN8m could increase DNA-
binding protein-induced curvature to better stimulate transcription or relieve repression. 
Additionally, one alternative theory that should be pursued further is that the 5 bp  
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Figure 10: Effect of sarA on mucoid colony morphology. Bacterial colonies from 
strains RN4220∆ica, RN4220∆ica+pBT9-M1, and RN4220∆ica∆sarA+pBT9-M1 were 
grown on Congo red agar (CRA). Strains containing pBT9 were grown on CRA 
containing chloramphenicol.  
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Figure 11: Effect of sarA on PNAG production. PNAG slot blot analysis of S. aureus 
strains producing different amounts of plasmid encoded PNAG; probed with PNAG-
specific polyclonal antiserum. Samples for both strains containing the mucoid plasmid 
pBT9-M1 were diluted 1:10 further than indicated prior to immobilization on membrane. 
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Figure 12: Effect of sarA on ica mRNA transcript levels. Real-time RT-PCR analysis 
of icaC mRNA transcript was performed. Bars represent the mean fold difference in 
transcript amount relative to strain RN4220∆ica+pBT9-M1 with biological replicates n = 
3, and error bars indicate the standard deviations. Statistical comparison (unpaired t 
test) of RN4220∆ica+pBT9-M1 versus RN4220∆ica∆sarA+pBT9-M1 gave a P value of 
<0.0015.  
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 deletion produces its effect by inducing a 180 degree turn in the helical face of 
downstream DNA elements, potentially optimizing transcription activating interactions 
(between RNA polymerase and DNA, or another effect0r protein). 
 SarA is a positive regulator of icaADBC transcription that is known to bind to the 
ica promoter region (Tormo et al., 2005). While the exact binding site(s) is not known, 
we observed that the MN8m 5 bp deletion disrupts a putative SarA binding site as 
suggested by Tormo et al. (2005), leading us to hypothesize that binding of SarA might 
be altered in strain MN8m, increasing icaADBC transcription. However, we 
demonstrated through electrophoretic mobility shift assays that there is no detectable 
difference in the binding affinity of SarA to either the MN8 or MN8m promoter regions. 
We were able to conclude that there are likely to be multiple SarA binding sites within 
this region of DNA; and although it is not clear exactly where on the DNA SarA is 
binding, we intend to use our existing system to identify the preferred SarA binding sites 
to determine if sequence consensus is important. It is also worthy to note that we have 
devised a reliable in vitro method for heterologous expression and efficient purification 
of large quantities of recombinant SarA that is functionally active. 
 The most interesting observations of our work addressed the involvement of 
SarA in the constitutive transcriptional activation of icaADBC in MN8m. We initially 
theorized that while SarA is still capable of binding the promoter in such a way as to 
alter DNA element spacing (although it does not lie between the -10 and -35 regions), 
the 5-bp deletion responsible for the mucoid phenotype maximizes this spacing even in 
the absence of SarA, rendering SarA non-essential for ica expression in MN8m. This 
hypothesis has thus far been supported by our observations that the mucoid colony 
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morphology and hyper-PNAG production is maintained in a SarA-negative mucoid strain 
background. However, we concurrently observed that not only was SarA not necessary 
but that its absence increased icaADBC transcript levels and detectable PNAG 
production. These results expanded our hypothesis to include the likelihood that not 
only is SarA no longer responsible for ica expression, its presence appears to interfere 
with transcriptional activation. This conclusion is unique in that SarA is a well-
characterized positive regulator of icaADBC, and here we have demonstrated that in the 
MN8m strain background it acts as a negative regulator. This is possibly due to the 
physical presence of SarA bound to the promoter sterically hindering even greater 
transcription initiation by another effector, possibly RNA polymerase alone (auto-
activation of transcription) or other unknown transcription factors. 
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CHAPTER 4 
Characterizing Novel Phase Variation of Poly-N-Acetylglucosamine in 
Staphylococcus aureus 
 
 
 
Introduction 
Phase variation functions as a reversible on/off switch for the expression of a 
particular gene. The result is commonly an alteration in the expression of some cell 
surface-expressed antigen. Slipped-strand mispairing is one mechanism that can lead 
to the production of a phase variant. Slipped-strand mispairing occurs during DNA 
replication when there is mispairing between mother and daughter DNA strands in 
regions of DNA that contain simple 1-10 nucleotide repeats (Levinson & Gutman, 1987). 
This results in the addition or subtraction of one or more repeats that can bring about a 
change in transcriptional efficiency or shift the reading frame to alter or halt translation.   
We found previously that a 5-nucleotide deletion mutation within the icaADBC 
promoter of strain MN8m was sufficient to induce constitutive transcription of the 
icaADBC genes and high-level PNAG production, resulting in a mucoid phenotype and 
strong biofilm production (Jefferson et al., 2003). In the present study, we noted that 
growth of the mucoid strains in liquid culture resulted in the rapid accumulation of non-
mucoid variants suggesting that either mutation to the non-mucoid phenotype occurred 
at high frequency or that the non-mucoid variants had a selective growth advantage. We 
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investigated this phenomenon and found that the most frequent mutation leading to the 
phenotypic variation was a slipped-strand mispairing in icaC.  
 
Results 
Non-mucoid variants accumulate in cultures of a mucoid S. aureus strain 
S. aureus strain MN8m is a spontaneous PNAG-overproducing mutant of strain 
MN8 (Jefferson et al., 2003). It is highly aggregative in liquid culture whereas non-
mucoid strains are dispersed, making the culture turbid (Fig. 13). We found that MN8m 
cultures frequently exhibited an appearance that was somewhere between that of a 
turbid, non-mucoid strain and an auto-aggregative mucoid strain (Fig. 13). When these 
cultures were plated on Congo red agar (CRA), both mucoid colonies, which appear dry 
with irregular edges, and non-mucoid colonies, which are slick, circular, and 
occasionally surrounded by a transparent red perimeter, were observed (Fig. 14). 
Several of the non-mucoid MN8m variants were isolated and assigned names based on 
JB10-22; one of the strains selected for further characterization was JB12.  We 
compared the biofilm-forming ability of the non-mucoid variant JB12 to MN8 (the strain 
from which MN8m derived), which produces a low level of PNAG (considered wild-type), 
and to the PNAG-negative strain MN8Δica (Fig. 15). The JB12 strain displayed a 
significant decrease in biofilm formation, most closely resembling the PNAG-negative 
strain MN8Δica.  
 
Analysis of non-mucoid variant JB12 to determine PNAG expression 
The finding that JB12 biofilms resembled those of the PNAG-negative strain 
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Figure 13: Variation in MN8m planktonic growth phenotype. Liquid cultures in 
TSBG of (A) highly aggregative mucoid MN8m, (B) non-mucoid MN8, and (C) MN8m 
with mixed appearance. 
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Figure 14. Colony morphology of non-mucoid variants isolated from mucoid 
strain MN8m. Bacterial colonies of MN8, MN8∆ica, MN8m, and the JB12 and JB17 
variants on Congo red agar (CRA) plates. 
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Figure 15. Biofilm formation by the non-mucoid variant, JB12. Biofilm formation 
was assessed by visualization of biofilms formed on microtiter plate wells by safranin 
staining and quantitative data was obtained by resuspending the safranin in acetic acid. 
Bars represent the mean OD562 nm of n = 6, and error bars indicate the standard 
deviations. Statistical comparison (unpaired t test) of MN8m versus JB17 gave a P 
value of <0.001. 
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MN8Δica suggested that PNAG production was severely abrogated or absent in JB12. 
To test this, we performed slot-blot analysis using PNAG-specific rabbit polyclonal 
antiserum.  As depicted in Figure 16, no PNAG was detected on the cell surface or in 
the spent media of JB12 cultures. Therefore, the molecular mechanism leading to the 
non-mucoid phenotype appeared to be mediating the variation through the loss of 
detectable levels of PNAG. 
 
icaADBC transcript level of JB12  
A 5 bp deletion in the icaADBC promoter region of MN8m is responsible for 
constitutive icaADBC transcription and the constitutive hyper-production of PNAG that 
characterizes strain MN8m (Jefferson et al., 2003). We sequenced this region of DNA in 
strain JB12 and found that the ica promoter region was identical to MN8m. The 
icaADBC genes are co-transcribed, so to determine levels of the full-length transcript, 
we quantified levels of the 3’-most transcript, icaC, by realtime RT-PCR. As shown in 
Figure 17, icaADBC transcript levels were more than 300-fold greater in MN8m than in 
the non-mucoid parent strain MN8 and the level remained elevated in the non-mucoid 
variant. These results indicate that the loss of PNAG production was not due to a 
decrease in the level of icaADBC transcript, but rather that it was mediated by a post-
transcriptional mechanism affecting PNAG synthesis.  
 
Identification of a frequent mutation within a repeat region of icaC  
Since the 5 bp promoter deletion remained and there was no detectable  
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Figure 16. PNAG production by the non-mucoid variant, JB12. PNAG slot blot 
analysis of S. aureus strains producing different amounts of PNAG; probed with PNAG-
specific polyclonal antiserum. Samples for both MN8m cell surface and spent media 
were diluted 1:10 prior to immobilization on membrane. 
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Figure 17. Levels of ica transcript in the non-mucoid variant, JB12. Real-time RT-
PCR analysis of icaC mRNA transcript was performed. Bars represent the mean fold 
difference in transcript amount relative to strain MN8 with n = 3, and error bars indicate 
the standard deviations. Statistical comparison (unpaired t test) of MN8m and JB12 
versus MN8 gave a P value of <0.001. 
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difference in icaADBC transcript levels, DNA sequencing of the entire operon was 
performed. A 4 bp insertion was identified in the coding region of icaC (Fig. 18), 
extending a small region of “ttta” repeats from three units to four. The insertion led to a 
shift in the translational reading frame and truncation of the protein, reducing IcaC from 
350 amino acids to 303. 
To confirm that the nucleotide insertion was responsible for loss of the mucoid 
phenotype, we complemented the icaC gene in trans. Expression of the intact icaC 
gene in strain JB12 from the IPTG-inducible plasmid pCL15, lead to restoration of the 
mucoid colony morphology on CRA plates (Fig. 19), PNAG synthesis (Fig. 21), and 
biofilm formation (Fig. 20). Introduction of the empty vector into the variant had no 
effect.  
Additionally, we found that variations in the number of 4 bp repeats in this region 
appears to be a frequent mutation among non-mucoid variants isolated from pure 
MN8m cultures. The icaADBC loci of twelve isolates with the PNAG-negative phenotype 
from different cultures were sequenced. Seven of these were shown to have either 
insertion or deletion of a repeat unit in the same region. Furthermore, examination of 
published S. aureus sequences revealed three clinical MRSA strains (TW20, JKD6008, 
and T0141) and two partially sequenced clinical isolates (SA21178 and SA21342) 
exhibiting 2-3 additional repeat units (Fig. 22) demonstrating that the phase variants 
occur in vivo.  
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Figure 18. Schematic representation of the ica locus showing the position of the 4 
bp insertion in the region of repeats identified in icaC of the non-mucoid variant 
JB12. 
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Figure 19. Effect of complementation of JB12 with icaC in trans on colony 
morphology. Bacterial colonies of MN8 and JB12 and JB12 on Congo red agar (CRA), 
and JB12+empty vector or icaC on CRA+Cm+ 1mM IPTG.  
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Figure 20. Effect of complementation of JB12 with icaC in trans on biofilm 
formation. Biofilms formed in TSBG or TSBG+Cm+1mM IPTG on microtiter plate wells 
were stained with safranin and the safranin was quantified by resuspending in acetic 
acid and measuring OD562 nm. Bars represent the mean of 6 replicates, and error bars 
indicate the standard deviations. Statistical comparison (unpaired t test) of JB12+pCL15 
(empty vector) versus JB12+pCL15-icaC gave a P value of <0.001. 
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Figure 21. Effect of complementation of JB12 with icaC in trans on PNAG 
production. PNAG slot blot of cell surface fractions cultured in TSBG or 
TSBG+Cm+1mM IPTG probed with polyclonal anti-PNAG antiserum (MN8m and 
JB12+pCL15-icaC samples were diluted 1:10 prior to immobilization on membrane 
whereas JB12 and JB12+pCL15 were not diluted). 
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Figure 22. Nucleotide sequence alignment of the region of repeats identified in 
icaC. Comparison of mucoid MN8m and non-mucoid isolate JB12 with five published 
sequences of S. aureus clinical isolates. 
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Isolation of JB12 mucoid variants    
 Phase variation is, by definition, an on/off switch. Therefore, if the mutation that 
we isolated was a product of phase variation, then we would expect the variant JB12 to 
revert to the mucoid phenotype. To determine whether or not the phenotype was 
reversible we plated cultures of JB12 onto CRA. We did not observe any mucoid 
colonies initially when we plated JB12, so we grew cultures on tissue culture-treated 
polystyrene for 36 hr to encourage adherence of PNAG-producing bacteria and plated 
the adherent fraction onto CRA. This selection method resulted in the isolation of 
mucoid colonies. To confirm that these JB12 mucoid variants supported our theory of 
phase variation and did not have a compensatory mutation elsewhere it the genome of 
ica locus, we sequenced 6 isolates from separate cultures. All 6 variants sequenced 
had lost the 4 bp repeat unit that was gained in JB12 meaning that they had reverted to 
MN8m genotype. These results support a mechanism of phase variation through slip-
strand mispairing. However, the requirement for a selection process to isolate mucoid 
revertants suggested that the number of revertants was very low. We hypothesized that 
this was due to a fitness cost imparted by high-level PNAG production. 
 
Fitness cost of PNAG over-production 
To determine if there was a fitness cost associated with constitutive PNAG 
synthesis, we inoculated competitive co-cultures of MN8m and JB12 equally and 
examined shifts in the population over time by assessing colony morphology on CRA. 
We observed that there does indeed appear to be significant growth advantage in the 
PNAG-negative variant JB12. Growth curves revealed slower growth in MN8m relative 
to JB12 (Fig. 23), while competitive co-culture of equal amounts MN8m and JB12 
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showed that JB12 almost completely took-over the culture in a relatively short amount of 
time (Fig. 24). Direct calculation of the fitness cost of PNAG over-production versus 
PNAG loss resulted in fitt  (relative bacterial fitness) values of +1.401 at 6 hours, and 
+1.386 at 12 hours, with a value greater than 1 indicating a significant fitness advantage 
of the JB12 PNAG-negative phenotype over the mucoid MN8m.  
 
Effect of partial function of PNAG synthesis pathway on cell survival 
Since only the function of IcaC appears to be altered in this phase variable 
control of PNAG production, we hypothesized that the remaining components of the 
synthesis pathway (IcaA, IcaD, and IcaB) that are still present in functional forms may 
have alternative roles within the cell. We compared the growth rates in liquid culture of 
MN8∆ica, which lacks all four genes and produces no PNAG synthesis proteins, and 
JB12, which has intact IcaA, IcaD, and IcaB, but found no difference. However, under 
starvation conditions, when the strains were switched to incubation in minimal media 
containing no carbon source, there was a significant difference in bacterial survival (Fig. 
25). Production of intact, and presumably functional IcaA, IcaD, and IcaB significantly 
increased survival of JB12 under these growth-limiting conditions. 
 
Discussion 
 This study was based upon our observation that cultures of the mucoid strain 
MN8m frequently appeared to be a mixture of mucoid and non-mucoid bacteria. We 
hypothesized that either there was a molecular mechanism for phase variation resulting 
in a mutation frequency higher than what would be expected for random mutagenesis or  
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Figure 23. Growth comparison of MN8m and JB12. Strains were grown in TSBG. 
Points represent the mean percent value of OD600 nm at each time point with n = 3, and 
error bars indicate the standard deviations.  
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Figure 24. Fitness of MN8m versus JB12. The competitive fitness of MN8m in co-
culture with PNAG-negative, non-mucoid JB12 was determined by combining the two 
strains and enumerating each strain over time. Bars represent the value of each 
phenotype as a percent of total population, determined by enumerating colonies on 
CRA. Values represent the mean of triplicate samples. 
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Figure 25. Influence of partial function in PNAG synthesis pathway on survival in 
minimal media. MN8m and JB12 were initially grown overnight in TSBG. The cells 
were collected and resuspended in minimal media lacking a carbon source to mimic 
starvation conditions. Points represent the mean percent value of cells enumerated at 
each time point relative to the starting populations with n = 3, and error bars indicate the 
standard deviations. Statistical comparison (unpaired t test) of MN8Δica and JB12 at 10 
hours and 24 hours gave a P value of <0.001. 
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that overproduction of PNAG was detrimental to growth and was associated with a 
strong selection bias for mutants. We attempted to determine the mutation frequency; 
however, results from different biologic replicates varied by over four orders of 
magnitude. We found that there was a strong competitive advantage for the non-mucoid 
variants. The growth advantage is likely responsible for the wide variation in apparent 
mutation frequency. Depending on the time-point during culture at which a mutation 
leading to the non-mucoid phenotype occurred, the variants would have more or less 
time to increase in numbers relative to the parent strain due to the growth advantage. 
Therefore, the final number of variants present at the end of the culture period would 
depend upon the timing of the first mutation event and would be stochastic.  
The growth advantage of the non-mucoid variants also explains our difficulty in 
isolating mucoid revertants from non-mucoid cultures. We had to grow cultures on 
tissue culture-treated polystyrene for three days and select for adherent bacteria in 
order to detect mucoid revertants on CRA. Due to the fitness cost associated with 
PNAG hyper-production, numbers of mucoid revertants would remain very low relative 
to the non-mucoid parent population. 
Despite our finding that the PNAG-negative variants enjoyed a fitness advantage, 
we hypothesize that it is unlikely for PNAG-negative variants to have a fitness 
advantage in vivo. Firstly, we were working with a mucoid variant that arose in vitro and 
produces approximately 1,000-fold more PNAG than most clinical isolates. Constitutive 
hyper-production of this large polysaccharide almost certainly bears a high metabolic 
cost, whereas normal, low-level PNAG production would not. Secondly, in vivo, PNAG 
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plays an important role in immune evasion and PNAG-negative variants would likely be 
more susceptible to neutrophil-mediated killing. It appears that antibody-mediated 
immunity against PNAG is somewhat complex and that only antibodies against 
deacetylated PNAG effectively mediate opsonophagocytosis (Maira-Litran et al., 2005). 
However, in the event that the host mounts an effective immune response, the capacity 
to switch PNAG production off could benefit the bacteria in vivo. It could also benefit the 
bacteria in conditions that favor the planktonic mode of growth.  
The 5 bp deletion in the MN8m ica promoter leads to constitutive icaADBC 
transcription and the accumulation of at least 300-fold more transcript than the clinical 
isolate parent strain MN8. Such high-level transcript production and protein synthesis 
would seem to be metabolically costly even in the absence of PNAG production. We 
therefore found it somewhat surprising that the most common mutation (7 out of 12 
variants) occurred within the last gene in the operon (icaC) and that transcript and Ica 
proteins were still being produced at MN8m levels. Furthermore, the insertion sequence 
IS256 has been shown to turn PNAG synthesis off through insertional inactivation of 
icaC (Kiem et al., 2004) suggesting again that mutation of IcaC is the preferred “off 
switch” for PNAG production. We tested our hypothesis that there might be some 
advantage to continuing synthesis of IcaA, IcaD, and IcaB even though PNAG is not 
produced in the absence of IcaC. Our results indicate that under nutrient-limiting 
conditions, possession of functional icaADB genes was advantageous for survival. It is 
possible that in the absence of functional IcaC, the remaining proteins are still capable 
of producing PNAG precursor oligomers within the cell. Therefore, perhaps these         
N-acetylglucosamine oligomers can function as a reserve store of UDP-N-acetyl-
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glucosamine under nutrient-limiting conditions and can be degraded to provide             
N-acetylglucosamine for other cellular process such as cell wall synthesis. Further work 
is needed to more clearly elucidate the roles of the IcaA, IcaD, and IcaB proteins 
alternative to their function in PNAG synthesis. 
We found that 7 out of 12 of the non-mucoid variants isolated in this study 
exhibited an insertion or deletion of 4 bp within a region of simple “ttta” repeats.  In 
JB12, a “ttta” repeat insertion extends the repeats in this region from three units to four. 
This is likely to be the result of slipped-strand mispairing during DNA replication. The 
mutation shifts the reading frame, leading to a premature stop codon and truncates the 
protein at 303 amino acids, 47 amino acids shorter than the full-length protein. 
Structural prediction indicates that the mutation disrupts a transmembrane domain of 
IcaC, suggesting that if the truncated protein is present in the bacteria, its location may 
be altered. We have preliminary evidence that supports the idea that this phase 
variation does have some in vivo relevance, since five clinical isolates have thus far 
been identified as possessing variations in the number of “ttta” repeats in this region. 
However, in vitro examination of the phenotypic effect of these variable numbers of 
repeats needs to be performed.
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CHAPTER 5 
Evidence of polarity/translational coupling between icaB and icaC of 
Staphylococcus aureus 
 
 
 
 
Introduction 
 
 A polar mutation affects the expression of distal genes, and is a frequent 
occurrence in prokaryotes. Commonly, a nonsense, frameshift, or insertion mutation 
near the promoter proximal region of an upstream gene in a co-transcribed operon 
significantly reduces the transcription or translation of downstream genes. One type of 
bacterial polarity affecting translation of an operon is called translational coupling. 
Translational coupling occurs when complete translation of a gene is necessary for 
efficient translation of a downstream gene, and was first identified in the E. coli 
tryptophan operon (Aksoy et al., 1984).  Coupled genes are commonly found to have 
overlapping translational start/stop sites, and the genes products are usually present in 
equimolar complexes. Translational coupling is therefore proposed as a molecular 
mechanism for maintaining stoichiometric balance between proteins in a synthetic 
pathway (Aksoy et al., 1984, Oppenheim & Yanofsky, 1980). There are currently three 
supported models of translational coupling. The first type occurs when base-pair 
structure within the mRNA masks the initiation site of the downstream gene, and a 
translating ribosome from the upstream gene is required to disrupt the secondary 
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structure when in proximity, exposing the start site and enabling translation exclusively 
by free ribosomes (Berkhout & van Duin, 1985). The second model relies on the same 
presence of secondary structure occluding the translational start site of the downstream 
gene, but the presence of the upstream translating ribosomes enables translation by 
either free ribosomes or continuation of the bound ribosomes (Berkhout et al., 1987, 
Das & Yanofsky, 1989). The third model of translational coupling occurs when there is 
poor binding of free ribosomes to the Shine-Delgarno sequence, or ribosomal binding 
site, of the downstream gene and only bound ribosomes from the upstream gene can 
efficiently reinitiate translation upon pausing at the overlap region (Govantes et al., 
1998, Ivey-Hoyle & Steege, 1992). 
 In the present study we continued our work characterizing the different molecular 
mechanisms responsible for the frequent non-mucoid variants that were previously 
observed to accumulate in mucoid Staphylococcus aureus strain MN8m cultures. While 
the majority of the mutations identified thus far were located in the icaC gene and 
characterized by complete loss of PNAG production, another non-mucoid variant was 
found to have a nonsense mutation in icaB producing the same phenotype. Given that 
previous efforts to delete the icaB gene in S. aureus did not result in a similar 
phenotype, we reasoned that the method of deletion by allelic exchange may have 
masked an underlying, previously unknown relationship between icaB and the 
downstream gene icaC.  We therefore hypothesized that a nonsense mutation early in 
icaB would have a polar effect on expression of icaC, most likely through translational 
coupling of the genes since the stop site of icaB overlaps with the start site of icaC. Our 
investigation into this phenomenon thus far has supported polarity between the genes, 
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and begun to elucidate the potential for translational coupling although the exact nature 
has yet to be fully defined. 
 
Results 
Isolation of biofilm-deficient, MN8m non-mucoid variant JB17 
As previously outline in Chapter 5, non-mucoid variants have been found to 
accumulate in pure cultures of the mucoid S. aureus strain MN8m. When these cultures 
were plated on Congo red agar (CRA), both mucoid colonies, which appear dry with 
irregular edges, and non-mucoid colonies, which are slick, circular, and occasionally 
surrounded by a transparent red perimeter, were observed (Fig. 14). Of the non-mucoid 
MN8m variants isolated, one named JB17 was also selected for further characterization.  
We compared the biofilm-forming ability of this non-mucoid variant to MN8 (the strain 
from which MN8m derived), which produces a low level of PNAG (considered wild-type), 
and to the PNAG-negative strain MN8Δica (Fig. 26). The JB17 strain displayed a 
significant decrease in biofilm formation, most closely resembling the PNAG-negative 
strain MN8Δica.  
 
Analysis of non-mucoid variant JB17 to determine PNAG expression 
The finding that JB17 biofilms resembled those of the PNAG-negative strain 
MN8Δica suggested that PNAG production was severely abrogated or absent in JB17. 
To test this, we performed slot-blot analysis using PNAG-specific rabbit polyclonal 
antiserum.  As depicted in Figure 27, no PNAG was detected on the cell surface or in 
the spent media of JB17 cultures. Therefore, the molecular mechanism leading to the  
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Figure 26. Biofilm formation by the non-mucoid variant, JB17. Biofilm formation 
was assessed by visualization of biofilms formed on microtiter plate wells by safranin 
staining and quantitative data was obtained by resuspending the safranin in acetic acid. 
Bars represent the mean OD562 nm of n = 6, and error bars indicate the standard 
deviations. Statistical comparison (unpaired t test) of MN8m versus JB17 gave a P 
value of <0.001. 
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Figure 27. PNAG production by the non-mucoid variant, JB17. PNAG slot blot 
analysis of S. aureus strains producing different amounts of PNAG; probed with PNAG-
specific polyclonal antiserum. Samples for both MN8m cell surface and spent media 
were diluted 1:10 prior to immobilization on membrane. 
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non-mucoid phenotype appeared to be mediating the variation through the loss of 
detectable levels of PNAG, similar to the initial observations of the previously 
characterized non-mucoid variant JB12, although not necessarily caused by the same 
mechanism. 
 
icaADBC transcript level of JB17  
A 5 bp deletion in the icaADBC promoter region of MN8m is responsible for 
constitutive icaADBC transcription and the constitutive hyper-production of PNAG that 
characterizes strain MN8m (Jefferson et al., 2003). We sequenced this region of DNA in 
strain JB17 and found that the 5 bp deletion was identical to MN8m. The icaADBC 
genes are co-transcribed, so to determine levels of the full-length transcript, we 
quantified levels of the 3’-most transcript, icaC, by realtime RT-PCR. As shown in 
Figure 28, icaADBC transcript levels were more than 300-fold greater in MN8m than in 
the non-mucoid parent strain MN8 and the level remained elevated in the non-mucoid 
variant JB17. These results indicate that the loss of PNAG production was not due to a 
decrease in the level of icaADBC transcript, but rather that it was mediated by a 
mechanism affecting PNAG synthesis.  
 
Identification of a nonsense mutation in icaB of strain JB17 
Since the 5 bp promoter deletion remained and there was no detectable 
difference in icaADBC transcript levels, DNA sequencing of the entire operon was 
performed.  A deletion of two base pairs near the beginning of icaB was found (Fig. 29),  
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Figure 28. Levels of ica transcript in the non-mucoid variant, JB17. Real-time RT-
PCR analysis of icaC mRNA transcript was performed. Bars represent the mean fold 
difference in transcript amount relative to strain MN8 with n = 3, and error bars indicate 
the standard deviations. Statistical comparison (unpaired t test) of MN8m and JB17 
versus MN8 gave a P value of <0.001. 
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causing a shift of translational reading frame and truncation of the protein; reducing 
IcaB from 290 amino acids to 62. 
However, previous work in our lab has shown that, while deletion of icaB 
prevents surface association by preventing deacetylation of PNAG, it does not cause a 
loss of PNAG production (Cerca et al., 2007). Instead, the PNAG is released into the 
spent medium. Yet the PNAG slot blot of strain JB17 (Fig. 27), which was now known to 
be an icaB mutant, did not show any PNAG present in the spent media. Therefore, we 
hypothesized that the nonsense mutation in icaB might have a polar effect on the 
expression of the downstream gene icaC, leading to the observed loss of PNAG 
production. In our efforts to confirm that the nonsense mutation was responsible for loss 
of the mucoid phenotype, we complemented the icaB gene in trans using the plasmid 
pCL15. Given our hypothesis, we also complemented JB17 in trans with either icaBC, 
icaC with the native Shine-Delgarno sequence intact, or icaC with the Shine-Delgarno 
sequence modified to an ideal consensus sequence. Only expression of the intact 
icaBC gene in strain JB17 from the IPTG-inducible plasmid pCL15 restored the mucoid 
biofilm formation (Fig. 30) and PNAG synthesis (Fig. 31). Introduction of the empty 
vector into the variant, or the other genes had no effect.  
 
Discussion 
 We have isolated a non-mucoid variant from the mucoid strain MN8m that is 
characterized by a loss of PNAG expression and biofilm formation. The mutation 
responsible for the phenotype variation was shown to have no effect on icaADBC  
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Figure 29. Schematic representation of the ica locus showing the position of the 
nonsense mutation identified in icaB of the non-mucoid variant JB17. The 
sequence highlighted in blue indicates icaB, the sequence highlighted in red indicates 
icaC, and the overlapping region of these two genes is highlighted in purple. 
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Figure 30. Effect of complementation in trans of JB17 with icaB, icaBC, or icaC 
with native/modified ribosomal binding site on biofilm formation. Biofilms formed 
in TSBG or TSBG+Cm+1mM IPTG on microtiter plate wells were stained with safranin 
and the safranin was quantified by resuspending in acetic acid and measuring OD562 nm. 
Bars represent the mean of 6 replicates, and error bars indicate the standard deviations. 
Statistical comparison (unpaired t test) of JB17+pCL15 (empty vector) versus 
JB17+pCL15-icaBC gave a P value of <0.001. 
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Figure 31. Effect of complementation in trans of JB17 with icaB, icaBC, or icaC 
with native/modified ribosomal binding site on PNAG production. PNAG slot blot of 
cell surface fractions cultured in TSBG or TSBG+Cm+1mM IPTG probed with polyclonal 
anti-PNAG antiserum (MN8m and JB17+pCL15-icaBC samples were diluted 1:10 prior 
to immobilization on membrane whereas JB17 and the other JB17+pCL15 strains were 
not diluted). 
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transcript levels despite the absence of PNAG expression, and was identified as a 2-bp 
deletion in icaB leading to a shift in translational reading frame (a nonsense mutation). 
Since IcaB is responsible for partial deacetylation of PNAG polymers, allowing them to 
remain surface associated, it is reasonable to expect an IcaB-negative mutant would 
produce full-length highly-acetylated PNAG that is released into the supernatant. This 
theory is supported by our previous work showing exactly this occurrence in S. aureus 
in which the icaB gene was deleted through in-frame removal of approximately 80% 
(Cerca et al., 2007). However, our work in this current study showed that the icaB 
nonsense mutant strain JB17 produced no detectable PNAG, either on the cell surface 
or in the culture supernatant. Additionally, complementation in trans of intact IcaB did 
not restore any detectable production or surface expression of PNAG. These results 
indicate that the use of the common techniques of creating a null mutant through allelic 
replacement or deleting a majority of the gene but leaving the remaining portion in 
frame, may have masked a previously unknown role of the icaB gene in the expression 
of the PNAG synthesis pathway.  
 Polarity between multiple genes in a co-transcribed operon is very common in 
prokaryotes, and is almost certainly relevant to these observations. IcaC is thought to 
be responsible for assembly of full-length PNAG polymers within the cell and 
translocating them to the cell surface, and is therefore considered an indispensable part 
of the PNAG synthesis pathway. We therefore hypothesized that a nonsense mutation 
early in icaB would have a polar effect on expression of icaC, leading to the loss of 
function of both gene products. Our observations that icaC transcript levels are not 
diminished by the mutation indicate that the polar effect does not alter transcription of 
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the downstream gene, meaning that the effect is most likely through translational 
coupling of the genes. 
 A specific nucleotide mutation is not in itself polar, instead the large region left 
untranslated between the two genes is (Zipser, 1969). Mutational studies have 
previously supported the importance of translation stopping at its normal site in close 
proximity to the start of the distal gene. Altering translation termination closer to the 
promoter increases the untranslated region and increases the polar effect, further 
reducing translation of the downstream gene. This has been shown to be due to one of 
the three models of translational coupling, all of which are dependent on ribosomes 
translating the upstream gene coming into close physical proximity to the initiation site 
of the downstream gene to either: relieve secondary structure occluding the start site, or 
to ‘slide’ after pausing and reinitiate translation themselves because free ribosomes are 
unable to recognize it. Our discovery that icaC complementation in trans did not restore 
PNAG production or secretion into the supernatant, led us to investigate the possibility 
that this last type of translational coupling was responsible for the JB17 phenotype. We 
tested this theory by expressing a modified version of the icaC gene in trans. It was 
modified by the replacement of the native ribosomal binding site with an optimized 
Shine-Delgarno sequence, which we hypothesized would restore PNAG production into 
the supernatant if poor binding of free ribosomes was responsible for the loss of 
translation. However, we were able to conclude that optimizing the ribosomal binding 
site of icaC so that it can be ‘seen’ by free ribosomes is not sufficient to restore PNAG 
production. Therefore, it is still possible that mRNA secondary structure at the 
translation initiation site of icaC is preventing translation because ribosomes translating 
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icaB prematurely disassociate too far upstream, an effect which might still be observed 
if the same base-pair structure is present in the mRNA originating from the plasmid 
encoded copy of icaC during complementation. To this point, our investigation into this 
phenomenon has thus supported a polar relationship between the genes icaB and icaC, 
and begun to elucidate the potential for translational coupling although the exact nature 
has yet to be fully defined. 
Our work has also addressed a common observation in other examples of polar 
mutations: the existence of two species of mRNA, both full-length versions and 
shortened transcripts that terminate near the mutation site (Zipser, 1969). Real-time RT-
PCR analysis of icaADBC transcription utilized icaC primers that are seated well 
downstream of the nonsense mutation in icaB, and showed no significant difference in 
icaC transcript level indicating that full-length mRNA is the dominant species in this 
particular example of polarity. A Northern blot could be used to more conclusively 
determine whether both potential species of mRNA are present and at what level. 
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CHAPTER 6 
Conclusions and Future Perspectives 
 
 
 
 
 Although the role of PNAG in S. aureus biofilms is perhaps the most studied of 
the potential adhesive molecules of the extracellular polymeric matrix, our knowledge is 
incomplete. The goal of this project was to utilize a strain that over-produces PNAG to 
better elucidate details of the expression and regulation of the icaADBC operon 
responsible for PNAG synthesis. We sought first to better understand promoter-
regulator interactions and promoter characteristics that influence transcriptional 
activation, and then to explore new evidence that PNAG expression can be modulated 
by phase variation within a biofilm population to reduce its contribution.  
The initial research focus of this project was to characterize the molecular 
mechanism underlying the 5 bp deletion in the S. aureus MN8m ica promoter region 
that is responsible for the conversion to mucoid PNAG hyper-production. We were able 
to conclude that the deletion has no effect on the intrinsic curvature of what we 
determined to be a linear region of DNA in the ica promoter. The deletion also has no 
apparent effect on the binding affinity of the positive regulator SarA, despite the fact that 
it disrupts a putative binding site. In the process of determining this lack of binding 
perturbation, it was noted that there are multiple potential binding SarA binding sites in 
the region selected and that binding of multiple proteins does occur in vitro. Therefore 
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further work should be devoted to determining if any specific sequence or site is a 
preferred binding sites within this region, which would help to provide insight into the 
current debate over whether SarA targets a nucleotide consensus sequence or a 
specific type of DNA structural topology for binding. Beyond these initial investigations 
into the characteristics of the MN8m promoter, we have concluded that the promoter 
deletion renders SarA no longer necessary for ica transcriptional activation. In this strain 
background, SarA does not act as a positive regulator of the icaADBC operon as it 
known to be; instead SarA functions as a negative regulator to inhibit transcriptional 
activation.  
In the process of working with strain MN8m we were given the opportunity to 
explore a phenomenon casually observed by handling liquid MN8m cultures: the 
frequent occurrence of what appeared to be a non-mucoid sub-population. This has led 
us to truly novel discoveries about regulation and expression of PNAG. Most notably, 
we have identified a novel mechanism for switching off PNAG production through the 
slipped-strand mispairing-mediated inactivation of IcaC. In vitro, elevated production of 
PNAG carried a fitness cost and consequently, PNAG-negative phase variants quickly 
increased in number relative to PNAG over-expressers. IcaC appears to be the chosen 
target for phase variation in PNAG production and loss of this protein appears to confer 
a survival advantage under nutrient-poor conditions relative to the loss of the entire 
operon, suggesting that the other proteins encoded within the ica locus could have 
some other function. The next step from this point would be to confirm that these 
remaining genes are in fact functional as we suppose by determining if the first two 
steps of the PNAG synthesis involving icaAD are still occurring. This could be 
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accomplished by detecting PNAG-precursors within the bacterial cell, and could also 
provide information about the function of the transmembrane domain lost in the icaC 
variation if short oligomers of PNAG versus full length polymers are found; i.e. does the 
mutation affect assembly or translocation function of IcaC? Evidence of this mechanism 
of phase variation in clinical isolates has supported the in vivo relevance of our 
observations, although future work needs to be devoted to confirming the predicted 
phenotype change resulting from variable repeats. Further pursuit of these variant 
clinical isolates may have greater implications in virulence and disease manifestation. 
While characterizing the non-mucoid variants isolated from MN8m that possess 
icaC mutations, we identified a mutant that was phenotypically identical but had a 
nonsense mutation further upstream in icaB. This mutant did not secrete full length 
PNAG into the surrounding milieu, as previous icaB mutational studies suggested it 
should. We concluded that our previous method of generating a null mutant had 
prevented the observation of a polar relationship between icaB and its downstream 
gene icaC, a relationship that was supported by restoration of PNAG expression 
through complementation in trans with icaBC. There are different types of polar 
mutation effects, one of which is translational coupling, which we believe is occurring in 
this operon. The translation termination location is critical in instances of translational 
coupling, and allelic exchange with an antibiotic cassette would have prevented this 
polar effect when the ribosome translating the cassette read through it and paused near 
the icaC initiation site, allowing it to then be translated. Our work modifying the Shine-
Delgarno sequence indicates that further work is needed to identify the exact 
mechanism of translational coupling between these two genes, which could be 
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accomplished by removing the untranslated distance in-frame from between the icaB 
nonsense mutation and icaC and by exploring the possibility of mRNA secondary 
structure at the beginning of icaC. 
Given the clinical relevance of Staphylococcus aureus as an opportunistic 
pathogen responsible for a large range of infections that affect numerous sites of the 
human body, research into its expression and regulation of virulence factors could have 
significant impact of our understanding of their role in disease and potential treatment 
strategies. Poly-N-acetylglucosamine is a major component of the extracellular 
polymeric matrix of S. aureus biofilms, and its increased expression is sometimes a 
crucial step in the disease progression of biofilm-associated infections. PNAG is also 
present on the cell surface even when cells are not part of a biofilm and plays an 
important role in innate immune evasion, contributing to avoidance of 
opsonophagocytosis and resistance to antimicrobial peptides. Therefore, having a more 
complete basic scientific understanding of icaADBC expression and regulation could 
potentially be very useful. The work in this study has identified multiple new levels of ica 
expression regulation, including at the level of transcription through the activity of SarA, 
of translation through polarity between icaB and icaC, and modulating PNAG 
expression by direct nucleotide mutation resulting in phase variation. These 
observations are significant because cutting-edge therapeutic strategies are currently 
attempting to target virulence factors rather than viability. Anti-virulence therapies are 
ideal because they are less likely to result in the propagation of mutations leading to 
resistance since they exert less selective pressure upon the bacterial population. 
Therefore, the contributions of this study to our understanding of the regulation of one of 
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S. aureus’ key virulence factors may help to make future anti-virulence strategies more 
effective. 
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